<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20170631//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article" dtd-version="1.2d1" specific-use="production" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BIORXIV</journal-id>
<journal-title-group>
<journal-title>bioRxiv</journal-title>
<abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title>
</journal-title-group>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1101/363846</article-id>
<article-version>1.1</article-version>
<article-categories>
<subj-group subj-group-type="author-type">
<subject>Regular Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Contradictory Results</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Genetics</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Comprehensive cross-disorder analyses of <italic>CNTNAP2</italic> suggest it is unlikely to be a primary risk gene for psychiatric disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3901-7507</contrib-id>
<name>
<surname>Toma</surname>
<given-names>Claudio</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0636-4836</contrib-id>
<name>
<surname>Pierce</surname>
<given-names>Kerrie D.</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shaw</surname>
<given-names>Alex D.</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Heath</surname>
<given-names>Anna</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mitchell</surname>
<given-names>Philip B.</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schofield</surname>
<given-names>Peter R.</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4014-4490</contrib-id>
<name>
<surname>Fullerton</surname>
<given-names>Janice M.</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Neuroscience Research Australia, Sydney</institution>, <country>Australia</country></aff>
<aff id="a2"><label>2</label><institution>School of Medical Sciences, University of New South Wales, Sydney</institution>, <country>Australia</country></aff>
<aff id="a3"><label>3</label><institution>School of Psychiatry, University of New South Wales, Sydney</institution>, <country>Australia</country></aff>
<aff id="a4"><label>4</label><institution>Black Dog Institute, Prince of Wales Hospital, Sydney</institution>, <country>Australia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><bold>Corresponding author:</bold> Claudio Toma, Neuroscience Research Australia, Margarete Ainsworth Building, Barker Street, Randwick NSW 2031, Sydney, Australia. Tel.: (&#x002B;61) 29399 1890; Email: <email>c.toma@neura.edu.au</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<year>2018</year></pub-date>
<elocation-id>363846</elocation-id>
<history>
<date date-type="received">
<day>06</day>
<month>7</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>06</day>
<month>7</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>7</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2018, Posted by Cold Spring Harbor Laboratory</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license>
</permissions>
<self-uri xlink:href="363846.pdf" content-type="pdf" xlink:role="full-text"/>
<abstract>
<title>ABSTRACT</title>
<p>The contactin-associated protein-like 2 <italic>(CNTNAP2)</italic> gene is a member of the neurexin superfamily. <italic>CNTNAP2</italic> was implicated in the cortical dysplasia-focal epilepsy (CDFE) syndrome, a recessive disease characterized by intellectual disability, epilepsy, language impairments and autistic features. Associated SNPs and heterozygous deletions in <italic>CNTNAP2</italic> have also frequently been reported in autism, schizophrenia and other psychiatric or neurological disorders. We aim here to gain conclusive evidence for the role of <italic>CNTNAP2</italic> in susceptibility to psychiatric disorders by the comprehensive analysis of large genomic datasets. In this study we used: i) summary statistics from the Psychiatric Genomics Consortium (PGC) GWAS; ii) examined all reported <italic>CNTNAP2</italic> structural variants in patients and controls; iii) performed cross-disorder analysis of functional or previously associated SNPs; iv) and conducted burden tests for pathogenic rare variants using sequencing data (4,483 ASD and 6,135 schizophrenia cases, and 13,042 controls).</p>
<p>In a CNV mircroarray study, we previously identified a 131kb deletion in <italic>CNTNAP2</italic> intron 1, removing a FOXP2 transcription factor binding site in an extended BD family. Here we perform a quantitative-PCR validation showing imperfect segregation with disease (5 bipolar disorder relatives). The distribution of CNVs across <italic>CNTNAP2</italic> in psychiatric cases from previous reports was no different from controls of the database of genomic variants. Gene-based association testing did not implicate common variants in autism, schizophrenia or other psychiatric phenotypes. The association of proposed functional SNPs rs7794745 and rs2710102, reported to influence brain connectivity, was not replicated; nor did functional SNPs yield significant results in meta-analysis across psychiatric disorders. Disrupting <italic>CNTNAP2</italic> rare variant burden was not higher in autism or schizophrenia compared to controls. This large comprehensive candidate gene study indicates that <italic>CNTNAP2</italic> may not be a robust risk gene for psychiatric phenotypes.</p>
<sec>
<title>AUTHOR SUMMARY</title>
<p>Genetic mutations that disrupt both copies of the <italic>CNTNAP2</italic> gene lead to severe disease, characterized by profound intellectual disability, epilepsy, language difficulties and autistic traits. Researchers hypothesized that this gene may also be involved in autism given some overlapping clinical features with this disease. Indeed, several large DNA deletions affecting one of the two copies of <italic>CNTNAP2</italic> were found in some patients with autism, and later also in patients with schizophrenia, bipolar disorder, ADHD and epilepsy, suggesting that this gene was involved in several psychiatric or neurologic diseases. Other studies considered genetic sequence variations that are common in the general population, and suggested that two such sequence variations in <italic>CNTNAP2</italic> predispose to psychiatric diseases by influencing the functionality and connectivity of the brain. In the current study, we report the deletion of one copy of <italic>CNTNAP2</italic> in a patient with bipolar disorder from an extended family where five relatives were affected with this condition. To better understand the involvement of <italic>CNTNAP2</italic> in risk of mental illness, we performed several genetic analyses using a series of large publically available or in-house datasets, comprising many thousands of patients and controls. Despite the previous consideration of <italic>CNTNAP2</italic> as a strong candidate gene for autism or schizophrenia, we show that neither common, deletion nor ultra-rare variants in <italic>CNTNAP2</italic> are likely to play a major role in risk of psychiatric diseases.</p>
</sec>
</abstract>
<counts>
<page-count count="36"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>INTRODUCTION</title>
<p>The contactin-associated protein-like 2 (<italic>CNTNAP2</italic>) is located on chromosome 7q35-36.1, and consists of 24 exons spanning 2.3Mb, making it one of the largest protein coding genes in the human genome. This gene encodes the CASPR2 protein, related to the neurexin superfamily, which localises with potassium channels at the juxtaparanodal regions of the Ravier nodes in myelinated axons, playing a crucial role in the clustering of potassium channels required for conduction of axon potentials [<xref ref-type="bibr" rid="c1">1</xref>]. <italic>CNTNAP2</italic> is expressed in the spinal cord, prefrontal and frontal cortex, striatum, thalamus and amygdala; this pattern of expression is preserved throughout the development and adulthood [<xref ref-type="bibr" rid="c2">2</xref>, <xref ref-type="bibr" rid="c3">3</xref>]. Its function is related to neuronal migration, dendritic arborisation and synaptic transmission [<xref ref-type="bibr" rid="c4">4</xref>]. The crucial role of <italic>CNTNAP2</italic> in the human brain became clear when Strauss <italic>et al</italic>, reported homozygous mutations in Old Order Amish families segregating with a severe Mendelian condition, described as cortical dysplasia-focal epilepsy (CDFE) syndrome (OMIM 610042) [<xref ref-type="bibr" rid="c5">5</xref>]. In 2009, additional patients with recessive mutations in <italic>CNTNAP2</italic> were reported, with clinical features resembling Pitt-Hopkins syndrome [<xref ref-type="bibr" rid="c6">6</xref>]. To date 33 patients, mostly from consanguineous families, have been reported with homozygous or compound deletions and truncating mutations in <italic>CNTNAP2</italic> [<xref ref-type="bibr" rid="c5">5</xref>-<xref ref-type="bibr" rid="c9">9</xref>], and are collectively described as having CASPR2 deficiency disorder [<xref ref-type="bibr" rid="c7">7</xref>]. The common clinical features in this phenotype include severe intellectual disability (ID), seizures with age of onset at two years and concomitant speech impairments or language regression. The phenotype is often accompanied by dysmorphic features, autistic traits, psychomotor delay and focal cortical dysplasia.</p>
<p><italic>CNTNAP2</italic> is also thought to contribute to the phenotype in patients with interstitial or terminal deletions at 7q35 and 7q36. Interstitial or terminal deletions encompassing <italic>CNTNAP2</italic> and several other genes have been described in individuals with ID, seizures, craniofacial anomalies, including microcephaly, short stature and absence of language [<xref ref-type="bibr" rid="c10">10</xref>]. The severe language impairments observed in patients with homozygous mutations or karyotypic abnormalities involving <italic>CNTNAP2</italic> suggested a possible functional interaction with <italic>FOXP2</italic>, a gene for which heterozygous mutations lead to a monogenic form of language disorder [<xref ref-type="bibr" rid="c11">11</xref>]. Interestingly, <italic>Vernes et al.,</italic> found that the FOXP2 transcription factor has a binding site in intron 1 of <italic>CNTNAP2</italic>, regulating its expression [<xref ref-type="bibr" rid="c12">12</xref>]. Considering that a large proportion of autistic patients show language impairments and most individuals with homozygous mutations in <italic>CNTNAP2</italic> manifest autistic features, several studies investigated the potential involvement of <italic>CNTNAP2</italic> in autism spectrum disorder (ASD). In particular, two pioneering studies showed that single nucleotide polymorphism (SNP) markers rs2710102 and rs7794745 were associated with risk of ASD [<xref ref-type="bibr" rid="c13">13</xref>, <xref ref-type="bibr" rid="c14">14</xref>]. Moreover, in subsequent studies, rs2710102 was implicated in early language acquisition in the general population [<xref ref-type="bibr" rid="c15">15</xref>], and showed functional effects on brain activation in neuroimaging studies [<xref ref-type="bibr" rid="c16">16</xref>-<xref ref-type="bibr" rid="c19">19</xref>]. Furthermore, genotypes at rs7794745 were associated with reduced grey matter volume in the left superior occipital gyrus in two independent studies [<xref ref-type="bibr" rid="c20">20</xref>, <xref ref-type="bibr" rid="c21">21</xref>], and alleles of this SNP were reported to affect voice-specific brain function [<xref ref-type="bibr" rid="c22">22</xref>]. Genetic associations with ASD for these, and several other SNPs in <italic>CNTNAP2</italic>, have been reported in a number of studies [<xref ref-type="bibr" rid="c23">23</xref>-<xref ref-type="bibr" rid="c28">28</xref>]. Along with the first reports of variants associated with ASD, copy number variant (CNV) deletions have also been described in ID or ASD patients, which were proposed to be highly penetrant disease-causative mutations [<xref ref-type="bibr" rid="c13">13</xref>, <xref ref-type="bibr" rid="c29">29</xref>-<xref ref-type="bibr" rid="c38">38</xref>]. To better understand the role of <italic>CNTNAP2</italic> in ASD pathophysiology, knockout mice were generated. Studies of these mice reported several neuronal defects when both copies of <italic>CNTNAP2</italic> are mutated: abnormal neuronal migration, reduction of GABAergic interneurons, deficiency in excitatory neurotransmission, and the delay of myelination in the neocortex [<xref ref-type="bibr" rid="c2">2</xref>, <xref ref-type="bibr" rid="c39">39</xref>, <xref ref-type="bibr" rid="c40">40</xref>].</p>
<p>These intriguing findings prompted additional investigations of <italic>CNTNAP2</italic> across other psychiatric disorders or language-related traits, with additional reports of variants being associated with schizophrenia (SCZ), bipolar disorder (BD), specific language impairment (SLI) and several other phenotypes or traits [<xref ref-type="bibr" rid="c12">12</xref>, <xref ref-type="bibr" rid="c15">15</xref>, <xref ref-type="bibr" rid="c41">41</xref>-<xref ref-type="bibr" rid="c50">50</xref>]. Consecutively, other studies reported CNV deletions in <italic>CNTNAP2</italic> in other psychiatric phenotypes such as schizophrenia [<xref ref-type="bibr" rid="c51">51</xref>, <xref ref-type="bibr" rid="c52">52</xref>], bipolar disorder [<xref ref-type="bibr" rid="c52">52</xref>-<xref ref-type="bibr" rid="c54">54</xref>], and ADHD [<xref ref-type="bibr" rid="c55">55</xref>]; neurological disorders [<xref ref-type="bibr" rid="c56">56</xref>-<xref ref-type="bibr" rid="c61">61</xref>]; and language-related phenotypes [<xref ref-type="bibr" rid="c61">61</xref>-<xref ref-type="bibr" rid="c65">65</xref>]. Interestingly, several of these structural variants were found in intron 1 of <italic>CNTNAP2</italic>, encompassing the FOXP2 transcription factor binding site.</p>
<p>Our group recently performed CNV analysis in extended families with bipolar disorder [<xref ref-type="bibr" rid="c66">66</xref>], and found an intronic deletion in one individual which removed the FOXP2 binding site, prompting the need for a segregation analysis in this family. We therefore aimed in this current study to examine the evidence for a role of the <italic>CNTNAP2</italic> gene in multiple psychiatric phenotypes, performing a comprehensive analysis of common and rare variants, CNVs and <italic>de novo</italic> mutations using both in-house data and publically available datasets.</p>
</sec>
<sec id="s2">
<title>RESULTS</title>
<sec id="s2a">
<title>Examination of an intronic deletion in CNTNAP2 in an extended family with bipolar disorder</title>
<p>CNV microarray analysis was performed in two affected individuals from an extended family which included five relatives affected with bipolar I disorder. A drop in signal intensity for 340 consecutive probes was compatible with a deletion of 131 kb in intron 1 of <italic>CNTNAP2</italic> (hg19/chr7:146203548-146334635; <xref ref-type="fig" rid="fig1">Fig 1A</xref>). The deletion encompasses the described binding site for the transcription factor FOXP2 (hg19/chr7:146215016-146215040) [<xref ref-type="bibr" rid="c12">12</xref>]. The deletion was detected in one of the two affected individuals examined. To infer deletion segregation amongst relatives, WES-derived genotypes were used to create haplotypes across chromosome 7q35 (<xref ref-type="fig" rid="fig1">Fig 1B</xref>). The WES-derived haplotype analysis was uninformative due to incomplete genotype data (unaffected descendants of deceased patient 8404 not included in the WES study) and a likely recombination at 7q35 in the family. Thus experimental validation (in patient 8401) and CNV genotyping via quantitative PCR (qPCR) was performed in all individuals with DNA available from this family to assess the presence of the <italic>CNTNAP2</italic> intronic deletion. The deletion was validated in subject 8401, and was also detected in one unaffected descendant of deceased patient 8404 (<xref ref-type="fig" rid="fig1">Fig 1C</xref>), implying that this CNV would have been present in affected subject 8404, had DNA been available. The structural variant did not segregate with disease status in this family, and is unlikely to be a highly penetrant variant as it was observed also in an unaffected relative (<xref ref-type="fig" rid="fig1">Fig 1B</xref>).
<fig id="fig1" position="float" fig-type="figure">
<label>Fig 1.</label>
<caption><title>CNV deletion encompassing intron 1 of <italic>CNTNAP2</italic> in an extended family with bipolar disorder.</title>
<p>A) CytoScan HD array output image shows the position of the drop in signal intensity of 340 probes, indicating a deletion spanning 131kb (chr7:146203548-146334635; GRCh37/hg19) found in the patient 8401. The position of the FOXP2 binding site within the deletion is shown above. B) The bipolar pedigree includes five patients with bipolar disorder I (BPI) across two generations. Symbols: _, individuals with DNA available; &#x0026;, individuals with whole exome data; #, individuals analysed for genome-wide CNVs through the CytoScan HD array; blue squares, individuals included in CNV qPCR validation and genotyping analysis, for which heterozygous deletion carriers are indicated as &#x201C;&#x002B;/del&#x201D; and non-carriers are indicated as &#x201C;&#x002B;/&#x002B;&#x201D;. Inferred genotypes are in parentheses. C) Gene dosage results of the qPCR experiments validating the deletion in patient 8401, and showing the deletion in unaffected subject 8407.</p></caption>
<graphic xlink:href="363846_fig1.tif"/>
</fig></p>
</sec>
<sec id="s2b">
<title>Structural variants affecting CNTNAP2 amongst psychiatric phenotypes</title>
<p>Several deletions and duplications have been described in neuropsychiatric phenotypes thus far. In <xref ref-type="fig" rid="fig2">Fig 2</xref>, we present a comprehensive representation of all previously reported structural variants found in <italic>CNTNAP2</italic> in psychiatric disorders such as ASD or ID [<xref ref-type="bibr" rid="c13">13</xref>, <xref ref-type="bibr" rid="c29">29</xref>-<xref ref-type="bibr" rid="c38">38</xref>], schizophrenia or bipolar disorder (including the 131kb deletion found in the present study) [<xref ref-type="bibr" rid="c51">51</xref>-<xref ref-type="bibr" rid="c54">54</xref>], ADHD [<xref ref-type="bibr" rid="c55">55</xref>], neurologic disorders such as epilepsy, Tourette syndrome or Charcot-Marie-Tooth [<xref ref-type="bibr" rid="c56">56</xref>-<xref ref-type="bibr" rid="c60">60</xref>]; and finally language-related phenotypes such as speech delay, childhood apraxia of speech and dyslexia [<xref ref-type="bibr" rid="c62">62</xref>-<xref ref-type="bibr" rid="c65">65</xref>]. Interestingly, the structural variants reported so far frequently map in intron 1, overlapping with the 131kb deletion found in our extended family, and extend in some cases up to exon 4. The distribution of those structural variants across different phenotypes does not vary with those found in control populations from the database of genomic variants (<ext-link ext-link-type="uri" xlink:href="http://dgv.tcag.ca/dgv/app/home">http://dgv.tcag.ca/dgv/app/home</ext-link>) (<xref ref-type="fig" rid="fig2">Fig 2</xref>), suggesting that structural variants in <italic>CNTNAP2</italic> are not rare events associated exclusively to disease but are present with rare frequency in the general population.
<fig id="fig2" position="float" fig-type="figure">
<label>Fig 2.</label>
<caption><title>Overview of heterozygous CNVs spanning the <italic>CNTNAP2</italic> gene across several diseases.</title>
<p>Abbreviations: ID (Intellectual disability), ASD (autism spectrum disorder), SCZ (schizophrenia), BD (bipolar disorder), ADHD (Attention-deficit/hyperactivity disorder), EP (epilepsy), TS (Tourette syndrome), CMT2 (axonal Charcot-Marie-Tooth), and SS (Speech spectrum: speech delay, childhood apraxia of speech and dyslexia). In parenthesis is reported the reference to each study. PS refers to this present study. <sup>&#x2217;</sup>, additional rearrangements reported in this patient. The dashed lines represent the exons and the upper box shows the position of the FOXP2 binding site. In dark shading, CNVs&#x2265;80kb found in the general populations from the Database of Genomic Variants are shown.</p></caption>
<graphic xlink:href="363846_fig2.tif"/>
</fig></p>
</sec>
<sec id="s2c">
<title>Analysis of CNTNAP2 common and rare variation in the susceptibility of psychiatric disorders</title>
<p>During the last decade, several association studies have been performed to assess the role of common variants of <italic>CNTNAP2</italic> in several psychiatric phenotypes. The functional relationship between <italic>CNTNAP2</italic> and the language-associated transcription factor FOXP2 prompted many studies to focus on language traits in autism or speech-related phenotypes [<xref ref-type="bibr" rid="c12">12</xref>-<xref ref-type="bibr" rid="c15">15</xref>, <xref ref-type="bibr" rid="c23">23</xref>-<xref ref-type="bibr" rid="c28">28</xref>, <xref ref-type="bibr" rid="c46">46</xref>-<xref ref-type="bibr" rid="c48">48</xref>, <xref ref-type="bibr" rid="c50">50</xref>], but later, additional associations were also reported in other psychiatric phenotypes [<xref ref-type="bibr" rid="c41">41</xref>-<xref ref-type="bibr" rid="c45">45</xref>, <xref ref-type="bibr" rid="c49">49</xref>]. In <xref ref-type="table" rid="tbl1">Table 1</xref>, we summarise all markers found significantly associated in these previous studies, and report the corresponding <italic>P</italic>-<italic>value</italic> from the Psychiatric Genomics Consortium GWAS for seven major psychiatric disorders: ADHD, anorexia nervosa, ASD, bipolar disorder, MDD, OCD and schizophrenia. Nominal associations were found with ASD for the following markers: rs802524 (<italic>P</italic>&#x003D;0.016), rs802568 (<italic>P</italic>&#x003D;0.008), rs17170073 (<italic>P</italic>&#x003D;0.008), and rs2710102 (which is highly correlated with 4 SNPs: rs759178, rs1922892, rs2538991, rs2538976) (<italic>P</italic>&#x003D;0.036); with schizophrenia for rs1859547 (<italic>P</italic>&#x003D;0.044); with ADHD for rs1718101 (<italic>P</italic>&#x003D;0.038); in MDD for rs12670868 (<italic>P</italic>&#x003D;0.047), rs17236239 (<italic>P</italic>&#x003D;0.006), rs4431523 (<italic>P</italic>&#x003D;0.001); and with anorexia nervosa for rs700273 (<italic>P</italic>&#x003D;0.013). The nominal association at rs1770073 and rs2710102 in ASD represents the only case in which the phenotype matches between the original report and the PGC dataset. The two SNPs rs7794745 and rs2710102, which were repeatedly reported as being associated and proposed to be functional SNPs, were not strongly associated with any phenotype (the most significant signal being <italic>P</italic>&#x003D;0.036 for rs2710102 in autism). None of those associations survived corrections for multiple comparisons (<xref ref-type="table" rid="tbl1">Table 1</xref>).
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table 1.</label>
<caption><title>Common SNPs in <italic>CNTNAP2</italic> previously associated in psychiatric diseases, and their evidence for association in PGC datasets.</title></caption><graphic xlink:href="363846_tbl1.tif"/>
<graphic xlink:href="363846_tbl1_1.tif"/>
</table-wrap></p>
<p>Next, we explored the contribution of common variants across <italic>CNTNAP2</italic> by performing a gene-based association study in European populations using GWAS summary statistics from PGC data of seven psychiatric disorders (<xref ref-type="table" rid="tbl2">Table 2</xref>).
<table-wrap id="tbl2" orientation="portrait" position="float">
<label>Table 2.</label>
<caption><title>Gene-based tests for association of <italic>CNTNAP2</italic> across seven psychiatric disorders using GWAS summary statistics of the PGC data sets.</title></caption><graphic xlink:href="363846_tbl2.tif"/>
</table-wrap></p>
<p>The test included a dense coverage of SNPs across <italic>CNTNAP2:</italic> from 1,214 SNPs in MDD up to 12,264 SNPs in schizophrenia. The results suggest that common variants overall do not contribute to disease susceptibility of these phenotypes (<xref ref-type="table" rid="tbl2">Table 2</xref>). The most significant association observed was for MDD phase 1 analysis (<italic>P</italic>&#x003D;0.029), which is the dataset with the most modest coverage of markers.</p>
<p>In our final analysis of the PGC datasets, we selected 63 predicted functional SNPs in <italic>CNTNAP2</italic> and performed a cross-disorder meta-analysis, aimed to test evidence for association with common functional variants across psychiatric disorders. Nominal significance of association was observed for 11 predicted functional SNPs with <italic>P</italic>-<italic>values</italic> ranging from 0.01 and 0.05, but none survive correction for multiple comparisons (<xref ref-type="table" rid="tbl3">Table 3</xref>).
<table-wrap id="tbl3" orientation="portrait" position="float">
<label>Table 3.</label>
<caption><title>Cross psychiatric disorders meta-analysis of predicted functional SNPs.</title></caption><graphic xlink:href="363846_tbl3.tif"/>
<graphic xlink:href="363846_tbl3_1.tif"/>
</table-wrap></p>
<p>The only SNP predicted to be functional and which was previously reported as being associated with autism was rs34712024 (<xref ref-type="table" rid="tbl2">Table 2</xref>) [<xref ref-type="bibr" rid="c25">25</xref>], but this variant was not associated with autism in PGC dataset (<italic>P</italic>&#x003D;0.67), nor other psychiatric phenotypes examined (<xref ref-type="table" rid="tbl2">Table 2</xref>).</p>
<p><italic>De novo</italic> variants in protein-coding genes which are predicted to be functionally damaging are considered to be highly pathogenic and have been extensively explored to implicate genes in psychiatric diseases, especially in ASD and schizophrenia [<xref ref-type="bibr" rid="c67">67</xref>]. We explored publically available sequence data from previous projects in psychiatric disorders to assess the rate of coding <italic>de novo</italic> variants in <italic>CNTNAP2</italic> using two databases (NPdenovo, <ext-link ext-link-type="uri" xlink:href="http://www.wzgenomics.cn/NPdenovo/">http://www.wzgenomics.cn/NPdenovo/</ext-link>; and denovo-db, <ext-link ext-link-type="uri" xlink:href="http://denovo-db.gs.washington.edu/denovo-db/">http://denovo-db.gs.washington.edu/denovo-db/</ext-link>). No truncating or missense variants were identified across <italic>CNTNAP2</italic> in 15,539 families (including 2,163 controls), and synonymous variants were reported in only two probands with developmental disorder (<xref ref-type="table" rid="tbl4">Table 4</xref>).
<table-wrap id="tbl4" orientation="portrait" position="float">
<label>Table 4.</label>
<caption><title><italic>CNTNAP2 de novo</italic> variants identified across several disease-specific sequencing projects.</title></caption><graphic xlink:href="363846_tbl4.tif"/>
</table-wrap></p>
<p>Finally, we explored the potential impact of pathogenic ultra-rare variants (URV) in <italic>CNTNAP2</italic> using available sequencing datasets of 4,483 patients with ASD and 6,135 patients with schizophrenia compared with 13,042 controls. We considered only those variants predicted to be pathogenic in both SIFT and Polyphen and which are ultra-rare (MAF&#x003C;0.0001 in Non-Finnish European population). No difference in the total number of URV was observed between ASD and controls (<italic>P</italic>&#x003D;0.11), or between schizophrenia patients and controls (<italic>P</italic>&#x003D;0.78) (<xref ref-type="table" rid="tbl5">Table 5</xref>).
<table-wrap id="tbl5" orientation="portrait" position="float">
<label>Table 5.</label>
<caption><title>Burden analysis of <italic>CNTNAP2</italic> ultra-rare variants (URVs) in ASD and SCZ.</title></caption><graphic xlink:href="363846_tbl5.tif"/>
</table-wrap></p>
</sec>
</sec>
<sec id="s3">
<title>DISCUSSION</title>
<p>During the last decade, the <italic>CNTNAP2</italic> gene has received considerable attention in the psychiatric genetics field, with a large body of studies examining gene dosage, common or rare variants across multiple major psychiatric disorders, which together provided compelling evidence that <italic>CNTNAP2</italic> may be a risk gene with pleiotropic effects in psychiatry. While homozygous mutations in this gene lead to a rare and severe condition described as CASPR2 deficiency disorder (CDD) [<xref ref-type="bibr" rid="c7">7</xref>], characterized by profound intellectual disability, epilepsy, language impairment or regression [<xref ref-type="bibr" rid="c7">7</xref>, <xref ref-type="bibr" rid="c8">8</xref>], heterozygous mutations or common variants have been suggested to be implicated in autism, whose features overlap with some observed in CDD. <italic>CNTNAP2</italic> is categorised in the SFARI database (<ext-link ext-link-type="uri" xlink:href="https://gene.sfari.org">https://gene.sfari.org</ext-link>) as a strong candidate gene for ASD (category 2.1). Heterozygous deletions encompassing the <italic>CNTNAP2</italic> gene were described not only in autism but also in a wide range of phenotypes, including psychiatric or neurologic disorders, and language-related deficiencies. These structural variants were generally described as causative or highly penetrant [<xref ref-type="bibr" rid="c13">13</xref>, <xref ref-type="bibr" rid="c29">29</xref>, <xref ref-type="bibr" rid="c31">31</xref>, <xref ref-type="bibr" rid="c55">55</xref>, <xref ref-type="bibr" rid="c57">57</xref>, <xref ref-type="bibr" rid="c59">59</xref>].</p>
<p>Here, we describe a new deletion in a bipolar disorder patient encompassing intron 1 of <italic>CNTNAP2</italic>, which overlaps with structural variants described in a number of other psychiatric patients. This heterozygous deletion, which removes the FOXP2 transcription factor binding site, was found in an individual with bipolar I disorder from an extended family with five affected members. This deletion was observed in only two of the affected relatives and was absent from two affected relatives, but was also observed in one unaffected relative who underwent diagnostic interview at age &#x003E;40 and therefore beyond the typical age of symptom onset. Hence, the deletion was not segregating with the disease and is unlikely to represent a highly penetrant risk variant in this family. Examination of the distribution of all structural variants described thus far in psychiatric or neurologic patients showed comparable mapping with those found in the general population, suggesting that structural variants affecting <italic>CNTNAP2</italic> may be less relevant in disease susceptibility than previously considered. Eleven CNVs are described in the general population against sixteen expected (z&#x003D;0.43) in ExAC database (<ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org">http://exac.broadinstitute.org</ext-link>), and the haploinsufficiency score (0.59) is relatively moderate [<xref ref-type="bibr" rid="c68">68</xref>], suggesting that <italic>CNTNAP2</italic> has a moderate tendency to be intolerant to structural variants. However, a case-control CNV analysis is needed in psychiatric disorders, but would require a very large sample due to the rarity of CNVs at this locus. A close clinical psychiatric examination of the 66 parents with heterozygous deletions across <italic>CNTNAP2</italic> of CDD provide information on the prevalence of psychiatric conditions in individuals carrying <italic>CNTNAP2</italic> CNVs. All heterozygous family members carrying deletions or truncating mutations were described as phenotypically healthy, suggesting a lack of correlation between these deletions and any major psychiatric condition. Furthermore, parents who were carriers for heterozygous deletions in psychiatric/neurologic patients were described as unaffected at the time of reporting [<xref ref-type="bibr" rid="c13">13</xref>, <xref ref-type="bibr" rid="c29">29</xref>, <xref ref-type="bibr" rid="c31">31</xref>, <xref ref-type="bibr" rid="c37">37</xref>, <xref ref-type="bibr" rid="c54">54</xref>, <xref ref-type="bibr" rid="c62">62</xref>], with the exception of one father of a proband with neonatal convulsion or another father of an epileptic patient reported as affected [<xref ref-type="bibr" rid="c56">56</xref>, <xref ref-type="bibr" rid="c59">59</xref>]. Moreover, discordant segregation for deletions in <italic>CNTNAP2</italic> was also observed in an ASD sib-pair [<xref ref-type="bibr" rid="c13">13</xref>]. Several psychiatric patients who were reported to carry heterozygous structural variants in <italic>CNTNAP2</italic> were also described with translocations or other chromosomal abnormalities [<xref ref-type="bibr" rid="c29">29</xref>, <xref ref-type="bibr" rid="c30">30</xref>, <xref ref-type="bibr" rid="c33">33</xref>, <xref ref-type="bibr" rid="c34">34</xref>, <xref ref-type="bibr" rid="c56">56</xref>, <xref ref-type="bibr" rid="c58">58</xref>, <xref ref-type="bibr" rid="c62">62</xref>-<xref ref-type="bibr" rid="c65">65</xref>], therefore it is possible that these aberrations may explain the phenotype independently from the observed CNVs in <italic>CNTNAP2</italic>.</p>
<p><italic>CNTNAP2</italic><sup>-/-</sup> knock-out mice have been proposed as valid animal model for ASD considering the phenotypic similarities between ASD and the CASPR2 deficiency disorder [<xref ref-type="bibr" rid="c2">2</xref>]. <italic>CNTNAP2</italic><sup>-/-</sup> knock-out mice showed abnormalities in the arborisation of dendrites, maturation of dendritic spines, defects in migration of cortical projection neurons, and reduction of GABAergic interneurons [<xref ref-type="bibr" rid="c2">2</xref>, <xref ref-type="bibr" rid="c4">4</xref>]. Controversially, ASD is not a core feature in the most recent patient series reported with CASPR2 deficiency disorder [<xref ref-type="bibr" rid="c7">7</xref>, <xref ref-type="bibr" rid="c8">8</xref>]. The association previously proposed around the relationship between heterozygous deletions in <italic>CNTNAP2</italic> and ASD does not have a support from mouse models, as heterozygous mice did not show any behavioural or neuropathological abnormalities that were observed in homozygous knockouts [<xref ref-type="bibr" rid="c2">2</xref>]. Notwithstanding this, it is possible that the combination of heterozygous <italic>CNTNAP2</italic> deletions in a genomic background of increased risk (through inheritance of other common and rare risk variants at other loci) may lead to psychiatric, behavioural or neuropathological abnormalities.</p>
<p>Common variants in <italic>CNTNAP2</italic> are another class of genetic variation associated with several psychiatric or language-related phenotypes. The most interesting finding from these studies converge on markers rs7794745 and rs2710102, originally reported in ASD [<xref ref-type="bibr" rid="c13">13</xref>, <xref ref-type="bibr" rid="c14">14</xref>], and replicated later in ASD or implicated in other phenotypes [<xref ref-type="bibr" rid="c12">12</xref>, <xref ref-type="bibr" rid="c15">15</xref>, <xref ref-type="bibr" rid="c23">23</xref>, <xref ref-type="bibr" rid="c24">24</xref>, <xref ref-type="bibr" rid="c46">46</xref>-<xref ref-type="bibr" rid="c48">48</xref>]. Neuroimaging studies have supported the notion that these common variants play a role in psychiatric disorders. SNP rs2710102 has been implicated in brain connectivity in healthy individuals [<xref ref-type="bibr" rid="c16">16</xref>, <xref ref-type="bibr" rid="c18">18</xref>, <xref ref-type="bibr" rid="c19">19</xref>], and rs7794745 was implicated in audio-visual speech perception [<xref ref-type="bibr" rid="c69">69</xref>], voice-specific brain function [<xref ref-type="bibr" rid="c22">22</xref>], and was associated with reduced grey matter volume in left superior occipital gyrus [<xref ref-type="bibr" rid="c20">20</xref>, <xref ref-type="bibr" rid="c21">21</xref>]. These studies focused principally on language tasks in general population, given the reported suggestive implications of <italic>CNTNAP2</italic> in language impairment traits of ASD or language-related phenotypes. However, the direct role of <italic>CNTNAP2</italic> in language is still unclear; indeed the language regression observed in patients with CASPR2 deficiency are concomitant with seizure onset and may represent a secondary phenotypic effect caused by seizures [<xref ref-type="bibr" rid="c7">7</xref>]. On the other hand, the first genetic association of rs7794745 and rs2710102 with ASD, as well as the other psychiatric diseases were based in studies with limited sample size, and recent studies failed to replicate associations between the two markers and ASD [<xref ref-type="bibr" rid="c70">70</xref>, <xref ref-type="bibr" rid="c71">71</xref>]. Individual alleles associated in the past with limited numbers of patients warrant replications in adequately powered samples to ascertain <italic>bona fide</italic> findings considering the small size effects of common variants [<xref ref-type="bibr" rid="c72">72</xref>], which we attempted here using the largest case-control cohorts currently publicly available (PGC datasets). We did not find evidence for significant association of previous reported common variants, nor did we find functional SNPs with a role across disorders, or observe a combined effect for common variants of <italic>CNTNAP2</italic> in the susceptibility of psychiatric disorders.</p>
<p>Rare variants of <italic>CNTNAP2</italic> both in the promoter or coding region were also reported to play a role in the pathophysiology of ASD [<xref ref-type="bibr" rid="c25">25</xref>, <xref ref-type="bibr" rid="c33">33</xref>]. A recent study including a large number of cases and controls did not find association of rare variants of <italic>CNTNAP2</italic> in ASD [<xref ref-type="bibr" rid="c73">73</xref>]. Here we report the largest sample investigated thus far in ASD and schizophrenia for rare variants in <italic>CNTNAP2</italic>, which suggest that rare variants from this gene do not play a major role in these two psychiatric disorders. Furthermore, the identification of <italic>de novo</italic> variants in <italic>CNTNAP2</italic> in combined psychiatric sequencing projects of over 15,500 trios suggest that <italic>de novo</italic> variants in this gene do not increase risk for psychiatric disorders.</p>
<p>While functional studies show a relationship between certain deletions or rare variants of <italic>CNTNAP2</italic> with neuronal phenotypes relevant to psychiatric illness [<xref ref-type="bibr" rid="c25">25</xref>, <xref ref-type="bibr" rid="c54">54</xref>, <xref ref-type="bibr" rid="c74">74</xref>], we show that the genetic link between these variants and psychiatric phenotypes is tenuous. However, this does not dispel the evidence that the <italic>CNTNAP2</italic> gene, or specific genetic variations within this gene, may have a real impact on neuronal functions or brain connectivity.</p>
<p>Nowadays we are able to combine large datasets to ascertain the real impact of candidate genes described in the past in psychiatric disorders. Here we performed analyses using large publically available datasets investigating a range of mutational mechanisms which impact variability of <italic>CNTNAP2</italic> across several psychiatric disorders. In conclusion, our results converge to show a limited or likely neutral role of <italic>CNTNAP2</italic> in the susceptibility of psychiatric disorders.</p>
</sec>
<sec id="s4">
<title>MATERIALS AND METHODS</title>
<sec id="s4a">
<title>Extended family with bipolar disorder and CNV in CNTNAP2</title>
<p>The extended family presented here (<xref ref-type="fig" rid="fig1">Fig 1B</xref>) provides a molecular follow-up from a previously reported whole exome sequencing (WES) study of multiplex BD families, augmented with CNV microarray data [<xref ref-type="bibr" rid="c66">66</xref>]. This multigenerational pedigree, was collected through the Mood Disorders Unit and Black Dog Institute at the Prince of Wales Hospital, Sydney, and the School of Psychiatry (University of New South Wales in Sydney) [<xref ref-type="bibr" rid="c75">75</xref>-<xref ref-type="bibr" rid="c79">79</xref>]. Consenting family members were assessed using the Family Interview for Genetic Studies (FIGS) [<xref ref-type="bibr" rid="c80">80</xref>], and the Diagnostic Interview for Genetic Studies (DIGS) [<xref ref-type="bibr" rid="c81">81</xref>]. The study was approved by the Human Research Ethics Committee of the University of New South Wales, and written informed consent was obtained from all participating individuals. Blood samples were collected for DNA extraction by standard laboratory methods. Three of the five relatives with bipolar disorder type I (BD-I) had DNA and WES-derived genotype data available, and six unaffected relatives with DNA and WES data were available for haplotype phasing and segregation analysis (<xref ref-type="fig" rid="fig1">Fig 1B</xref>).</p>
<p>Genome-wide CNV analysis was performed via CytoScan<sup>&#x00AE;</sup> HD Array (Affymetrix, Santa Clara, CA, USA) in 2 distal affected relatives (individuals 8410 and 8401; <xref ref-type="fig" rid="fig1">Fig 1B</xref>), using the Affymetrix Chromosome Analysis Suite (ChAS) software (ThermoFisher, Waltham, MA, USA). Detailed information on CNV detection and filtering criteria have been previously described [<xref ref-type="bibr" rid="c66">66</xref>]. We identified a 131kb deletion in intron 1 of <italic>CNTNAP2</italic> in individual 8401. WES-derived genotypes were used for haplotype assessment to infer CNV segregation amongst relatives, as previously described [<xref ref-type="bibr" rid="c66">66</xref>]. Next, we experimentally validated the <italic>CNTNAP2</italic> CNV via quantitative PCR (qPCR) in all available family members. Validation was performed in quadruplicate via a SYBR Green-based quantitative PCR (qPCR) method using two independent amplicon probes, each compared with two different reference amplicon probes in the <italic>FOXP2</italic> and <italic>RNF20</italic> genes (S1 Table). Experimental details are available upon request.</p>
</sec>
<sec id="s4b">
<title>Common variant association in CNTNAP2 using publically available datasets</title>
<p>We sought to replicate previously reported <italic>CNTNAP2</italic> SNP associations in a range of psychiatric phenotypes or traits using GWAS summary-statistic data of the Psychiatric Genomics Consortium (<ext-link ext-link-type="uri" xlink:href="https://med.unc.edu/pgc/results-and-downloads">https://med.unc.edu/pgc/results-and-downloads</ext-link>).</p>
<p>Firstly, we report the corresponding <italic>P</italic>-<italic>values</italic> of specific previously associated markers for case-control cohorts with autism spectrum disorder (ASD), schizophrenia (SCZ), bipolar disorder (BD), attention-deficit hyperactivity-disorder (ADHD), major depressive disorder (MDD), anorexia nervosa (AN), and obsessive compulsive disorder (OCD). If a specific SNP marker was not reported in an individual GWAS dataset, we selected another marker in high linkage disequilibrium (r<sup>2</sup>&#x007E;1, using genotype data from the CEU, TSI, GBR and IBS European populations in 1000genomes project; <ext-link ext-link-type="uri" xlink:href="http://www.internationalgenome.org">http://www.internationalgenome.org</ext-link>).</p>
<p>Next, a gene-based association for common variants was calculated with MAGMA [<xref ref-type="bibr" rid="c82">82</xref>], using variants within a 5 kb window upstream and downstream of <italic>CNTNAP2</italic>. Selected datasets were of European descent, derived from GWAS summary statistics of the Psychiatric Genomics Consortium (<ext-link ext-link-type="uri" xlink:href="https://med.unc.edu/pgc/results-and-downloads">https://med.unc.edu/pgc/results-and-downloads</ext-link>): SCZ (33,640 cases and 43,456 controls), BD (20,352 cases and 31,358 controls), ASD (6,197 and 7,377 controls), ADHD (19,099 cases and 34,194 controls) and MDD (9,240 cases and 9,519 controls) [<xref ref-type="bibr" rid="c83">83</xref>-<xref ref-type="bibr" rid="c87">87</xref>]. Analyses were performed combining two different models for higher statistical power and sensitivity when the genetic architecture is unknown: the combined <italic>P</italic>-<italic>value</italic> model, which is more sensitive when only a small proportion of key SNPs in a gene show association; and the mean SNP association, which is more sensitive when allelic heterogeneity is greater, and a larger number of SNPs show nominal association.</p>
<p>Finally, we selected SNPs predicted to be functional within a 5kb window upstream/downstream of <italic>CNTNAP2</italic> (e.g. located in transcription factor binding sites, miRNA binding sites etc; <ext-link ext-link-type="uri" xlink:href="https://snpinfo.niehs.nih.gov">https://snpinfo.niehs.nih.gov</ext-link>), and assessed a potential cross-disorder effect using GWAS summary statistics data of the PGC by performing a meta-analysis in PLINK [<xref ref-type="bibr" rid="c88">88</xref>]. The Cochran&#x2019;s Q-statistic and I<sup>2</sup> statistic were calculated to examine heterogeneity among studies. The null hypothesis was that all studies were measuring the same true effect, which would be rejected if heterogeneity exists across studies. For all functional SNPs, when heterogeneity between studies was I&#x003E;50&#x0025; (<italic>P</italic>&#x003C;0.05), the pooled OR was estimated using a random-effects model.</p>
</sec>
<sec id="s4c">
<title>Analysis of rare variants in CNTNAP2 in ASD and schizophrenia, and de novo variants across psychiatric cohorts</title>
<p>The impact of rare variants of <italic>CNTNAP2</italic> was assessed using sequencing-level data from the following datasets: WES from the Sweden-Schizophrenia population-based Case-Control cohort (6,135 cases and 6,245 controls; dbGAP accession: phs000473.v2.p2); ARRA Autism Sequencing Collaboration (490 BCM cases, BCM 486 controls, and 1,288 unrelated ASD probands from consent code c1; dbGAP accession: phs000298.v3.p2); Medical Genome Reference Bank (2,845 healthy Australian adults; <ext-link ext-link-type="uri" xlink:href="https://sgc.garvan.org.au/initiatives/mgrb">https://sgc.garvan.org.au/initiatives/mgrb</ext-link>); individuals from a Caucasian Spanish population (719 controls [<xref ref-type="bibr" rid="c89">89</xref>, <xref ref-type="bibr" rid="c90">90</xref>]); in-house ASD patients (30 cases; [<xref ref-type="bibr" rid="c91">91</xref>]); and previous published data set in ASD (2,704 cases and 2,747 controls [<xref ref-type="bibr" rid="c73">73</xref>]). The selection of potentially etiologic variants was performed based on their predicted pathogenicity (missense damaging in both SIFT and polyphen 2, canonical splice variants, stop mutation and indels) and minor allele frequency (MAF&#x003C;0.0001 in non-Finnish European populations using the Genome Aggregation Database; <ext-link ext-link-type="uri" xlink:href="http://gnomad.broadinstitute.org/">http://gnomad.broadinstitute.org/</ext-link>). A chi square statistic was used to compare separately the sample of schizophrenia patients (6,135 cases) and the combined ASD data sets (4,512 cases) with the combined control data sets (13,042 individuals).</p>
<p>Two databases for <italic>de novo</italic> variants were used to identify <italic>de novo</italic> variants in <italic>CNTNAP2</italic> [<xref ref-type="bibr" rid="c92">92</xref>, <xref ref-type="bibr" rid="c93">93</xref>], which comprise data for the following samples: autism spectrum disorder (6,171 families), schizophrenia (1,164 families), epilepsy (647 families), intellectual disability (1,101 families), developmental disorders (4,293 families) and controls (2,163).</p>
</sec>
</sec>
</body>
<back>
<ack>
<title>ACKNOWLEDGMENTS</title>
<p>This study was funded by the Australian National Medical and Health Research Council (NHMRC) Project Grant 1063960 and supported by NHMRC Project Grant 1066177, and Program Grant 1037196. We gratefully acknowledge the Janette Mary O&#x2019;Neil Research Fellowship (to JMF) and Mrs. Betty Lynch for supporting this work. DNA for the bipolar disorder family was extracted by Genetic Repositories Australia (GRA; <ext-link ext-link-type="uri" xlink:href="http://www.neura.edu.au/GRA">www.neura.edu.au/GRA</ext-link>), an Enabling Facility that was supported by NHMRC Enabling Grant 401184. DNA samples were prepared and whole exome sequenced at the Lottery State Biomedical Genomics Facility, University of Western Australia. We would also thank Xose S. Puente from the University of Oviedo (Spain) for providing us the data from a Spanish control population. We are grateful to all participants and their families, as well as clinical collaborators who were originally involved in collecting and phenotyping these families, including Laila Tabassum, and Adam Wright (UNSW).</p>
</ack>
<sec>
<title>FINANCIAL DISCLOSURES</title>
<p>The authors report no biomedical financial interests or potential conflicts of interest.</p>
</sec>
<ref-list>
<title>REFERENCES</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="journal"><string-name><surname>Poliak</surname> <given-names>S</given-names></string-name>, <string-name><surname>Salomon</surname> <given-names>D</given-names></string-name>, <string-name><surname>Elhanany</surname> <given-names>H</given-names></string-name>, <string-name><surname>Sabanay</surname> <given-names>H</given-names></string-name>, <string-name><surname>Kiernan</surname> <given-names>B</given-names></string-name>, <string-name><surname>Pevny</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal> <article-title>Juxtaparanodal clustering of Shaker-like K&#x002B; channels in myelinated axons depends on Caspr2 and TAG-1</article-title>. <source>The Journal of cell biology</source>. <year>2003</year>;<volume>162</volume>(<issue>6</issue>):<fpage>1149</fpage>&#x2013;<lpage>60</lpage>. doi: <pub-id pub-id-type="doi">10.1083/jcb.200305018</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">12963709</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC2172860</pub-id>.</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Penagarikano</surname> <given-names>O</given-names></string-name>, <string-name><surname>Abrahams</surname> <given-names>BS</given-names></string-name>, <string-name><surname>Herman</surname> <given-names>EI</given-names></string-name>, <string-name><surname>Winden</surname> <given-names>KD</given-names></string-name>, <string-name><surname>Gdalyahu</surname> <given-names>A</given-names></string-name>, <string-name><surname>Dong</surname> <given-names>H</given-names></string-name>, <etal>et al.</etal> <article-title>Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits</article-title>. <source>Cell</source>. <year>2011</year>;<volume>147</volume>(<issue>1</issue>):<fpage>235</fpage>&#x2013;<lpage>46</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.20U.08.040</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">21962519</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC3390029</pub-id>.</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Abrahams</surname> <given-names>BS</given-names></string-name>, <string-name><surname>Tentler</surname> <given-names>D</given-names></string-name>, <string-name><surname>Perederiy</surname> <given-names>JV</given-names></string-name>, <string-name><surname>Oldham</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Coppola</surname> <given-names>G</given-names></string-name>, <string-name><surname>Geschwind</surname> <given-names>DH.</given-names></string-name> <article-title>Genome-wide analyses of human perisylvian cerebral cortical patterning</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America.</source> <year>2007</year>;<volume>104</volume>(<issue>45</issue>):<fpage>17849</fpage>&#x2013;<lpage>54</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0706128104</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">17978184</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC2077018</pub-id>.</mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Anderson</surname> <given-names>GR</given-names></string-name>, <string-name><surname>Galfin</surname> <given-names>T</given-names></string-name>, <string-name><surname>Xu</surname> <given-names>W</given-names></string-name>, <string-name><surname>Aoto</surname> <given-names>J</given-names></string-name>, <string-name><surname>Malenka</surname> <given-names>RC</given-names></string-name>, <string-name><surname>Sudhof</surname> <given-names>TC</given-names></string-name>. <article-title>Candidate autism gene screen identifies critical role for cell-adhesion molecule CASPR2 in dendritic arborization and spine development</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America.</source> <year>2012</year>;<volume>109</volume>(<issue>44</issue>):<fpage>18120</fpage>&#x2013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1216398109</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">23074245</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC3497786</pub-id>.</mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>Strauss</surname> <given-names>KA</given-names></string-name>, <string-name><surname>Puffenberger</surname> <given-names>EG</given-names></string-name>, <string-name><surname>Huentelman</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Gottlieb</surname> <given-names>S</given-names></string-name>, <string-name><surname>Dobrin</surname> <given-names>SE</given-names></string-name>, <string-name><surname>Parod</surname> <given-names>JM</given-names></string-name>, <etal>et al.</etal> <article-title>Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2</article-title>. <source>The New England journal of medicine</source>. <year>2006</year>;<volume>354</volume>(<issue>13</issue>):<fpage>1370</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMoa052773</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">16571880</pub-id>.</mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Zweier</surname> <given-names>C</given-names></string-name>, <string-name><surname>de Jong</surname> <given-names>EK</given-names></string-name>, <string-name><surname>Zweier</surname> <given-names>M</given-names></string-name>, <string-name><surname>Orrico</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ousager</surname> <given-names>LB</given-names></string-name>, <string-name><surname>Collins</surname> <given-names>AL</given-names></string-name>, <etal>et al.</etal> <article-title>CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila</article-title>. <source>American journal of human genetics</source>. <year>2009</year>;<volume>85</volume>(<issue>5</issue>):<fpage>655</fpage>&#x2013;<lpage>66</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ajhg.2009.10.004</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">19896112</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC2775834</pub-id>.</mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Rodenas-Cuadrado</surname> <given-names>P</given-names></string-name>, <string-name><surname>Pietrafusa</surname> <given-names>N</given-names></string-name>, <string-name><surname>Francavilla</surname> <given-names>T</given-names></string-name>, <string-name><surname>La Neve</surname> <given-names>A</given-names></string-name>, <string-name><surname>Striano</surname> <given-names>P</given-names></string-name>, <string-name><surname>Vernes</surname> <given-names>SC.</given-names></string-name> <article-title>Characterisation of CASPR2 deficiency disorder&#x2010;&#x2010;a syndrome involving autism, epilepsy and language impairment</article-title>. <source>BMC medical genetics</source>. <year>2016</year>;<volume>17</volume>:<fpage>8</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12881-016-0272-8.</pub-id> PubMed PMID: <pub-id pub-id-type="pmid">26843181</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC4739328</pub-id>.</mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="journal"><string-name><surname>Smogavec</surname> <given-names>M</given-names></string-name>, <string-name><surname>Cleall</surname> <given-names>A</given-names></string-name>, <string-name><surname>Hoyer</surname> <given-names>J</given-names></string-name>, <string-name><surname>Lederer</surname> <given-names>D</given-names></string-name>, <string-name><surname>Nassogne</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Palmer</surname> <given-names>EE</given-names></string-name>, <etal>et al.</etal> <article-title>Eight further individuals with intellectual disability and epilepsy carrying bi-allelic CNTNAP2 aberrations allow delineation of the mutational and phenotypic spectrum</article-title>. <source>Journal of medical genetics</source>. <year>2016</year>;<volume>53</volume>(<issue>12</issue>):<fpage>820</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1136/jmedgenet-2016-103880</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">27439707</pub-id>.</mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="journal"><string-name><surname>Watson</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Crinnion</surname> <given-names>LA</given-names></string-name>, <string-name><surname>Tzika</surname> <given-names>A</given-names></string-name>, <string-name><surname>Mills</surname> <given-names>A</given-names></string-name>, <string-name><surname>Coates</surname> <given-names>A</given-names></string-name>, <string-name><surname>Pendlebury</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title>Diagnostic whole genome sequencing and split-read mapping for nucleotide resolution breakpoint identification in CNTNAP2 deficiency syndrome</article-title>. <source>American journal of medical genetics Part A</source>. <year>2014</year>;<volume>164A</volume>(<issue>10</issue>):<fpage>2649</fpage>&#x2013;<lpage>55</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ajmg.a.36679</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">25045150</pub-id>.</mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Kale</surname> <given-names>T</given-names></string-name>, <string-name><surname>Philip</surname> <given-names>M.</given-names></string-name> <article-title>An Interstitial Deletion at 7q33-36.1 in a Patient with Intellectual Disability, Significant Language Delay, and Severe Microcephaly</article-title>. <source>Case reports in genetics</source>. <year>2016</year>;<volume>2016</volume>:<fpage>6046351</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2016/6046351</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">28053794</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC5178345</pub-id>.</mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Lai</surname> <given-names>CS</given-names></string-name>, <string-name><surname>Fisher</surname> <given-names>SE</given-names></string-name>, <string-name><surname>Hurst</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Vargha-Khadem</surname> <given-names>F</given-names></string-name>, <string-name><surname>Monaco</surname> <given-names>AP.</given-names></string-name> <article-title>A forkhead-domain gene is mutated in a severe speech and language disorder</article-title>. <source>Nature</source>. <year>2001</year>;<volume>413</volume>(<issue>6855</issue>):<fpage>519</fpage>&#x2013;<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1038/35097076</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">11586359</pub-id>.</mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Vernes</surname> <given-names>SC</given-names></string-name>, <string-name><surname>Newbury</surname> <given-names>DF</given-names></string-name>, <string-name><surname>Abrahams</surname> <given-names>BS</given-names></string-name>, <string-name><surname>Winchester</surname> <given-names>L</given-names></string-name>, <string-name><surname>Nicod</surname> <given-names>J</given-names></string-name>, <string-name><surname>Groszer</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title>A functional genetic link between distinct developmental language disorders</article-title>. <source>The New England journal of medicine</source>. <year>2008</year>;<volume>359</volume>(<issue>22</issue>):<fpage>2337</fpage>&#x2013;<lpage>45</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMoa0802828</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">18987363</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC2756409</pub-id>.</mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Alarcon</surname> <given-names>M</given-names></string-name>, <string-name><surname>Abrahams</surname> <given-names>BS</given-names></string-name>, <string-name><surname>Stone</surname> <given-names>JL</given-names></string-name>, <string-name><surname>Duvall</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Perederiy</surname> <given-names>JV</given-names></string-name>, <string-name><surname>Bomar</surname> <given-names>JM</given-names></string-name>, <etal>et al.</etal> <article-title>Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene</article-title>. <source>American journal of human genetics</source>. <year>2008</year>;<volume>82</volume>(<issue>1</issue>):<fpage>150</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ajhg.2007.09.005</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">18179893</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC2253955</pub-id>.</mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Arking</surname> <given-names>DE</given-names></string-name>, <string-name><surname>Cutler</surname> <given-names>DJ</given-names></string-name>, <string-name><surname>Brune</surname> <given-names>CW</given-names></string-name>, <string-name><surname>Teslovich</surname> <given-names>TM</given-names></string-name>, <string-name><surname>West</surname> <given-names>K</given-names></string-name>, <string-name><surname>Ikeda</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title>A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism</article-title>. <source>American journal of human genetics</source>. <year>2008</year>;<volume>82</volume>(<issue>1</issue>):<fpage>160</fpage>&#x2013;<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ajhg.2007.09.015</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">18179894</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC2253968</pub-id>.</mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Whitehouse</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Bishop</surname> <given-names>DV</given-names></string-name>, <string-name><surname>Ang</surname> <given-names>QW</given-names></string-name>, <string-name><surname>Pennell</surname> <given-names>CE</given-names></string-name>, <string-name><surname>Fisher</surname> <given-names>SE.</given-names></string-name> <article-title>CNTNAP2 variants affect early language development in the general population</article-title>. <source>Genes, brain, and behavior</source>. <year>2011</year>;<volume>10</volume>(<issue>4</issue>):<fpage>451</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1601-183X.2011.00684.x</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">21310003</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC3130139</pub-id>.</mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Whalley</surname> <given-names>HC</given-names></string-name>, <string-name><surname>O&#x2019;Connell</surname> <given-names>G</given-names></string-name>, <string-name><surname>Sussmann</surname> <given-names>JE</given-names></string-name>, <string-name><surname>Peel</surname> <given-names>A</given-names></string-name>, <string-name><surname>Stanfield</surname> <given-names>AC</given-names></string-name>, <string-name><surname>Hayiou-Thomas</surname> <given-names>ME</given-names></string-name>, <etal>et al.</etal> <article-title>Genetic variation in CNTNAP2 alters brain function during linguistic processing in healthy individuals</article-title>. <source>American journal of medical genetics Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</source>. <year>2011</year>;<volume>156B</volume>(<issue>8</issue>):<fpage>941</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ajmg.b.31241</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">21987501</pub-id>.</mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Clemm von Hohenberg</surname> <given-names>C</given-names></string-name>, <string-name><surname>Wigand</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Kubicki</surname> <given-names>M</given-names></string-name>, <string-name><surname>Leicht</surname> <given-names>G</given-names></string-name>, <string-name><surname>Giegling</surname> <given-names>I</given-names></string-name>, <string-name><surname>Karch</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> <article-title>CNTNAP2 polymorphisms and structural brain connectivity: a diffusion-tensor imaging study</article-title>. <source>Journal of psychiatric research</source>. <year>2013</year>;<volume>47</volume>(<issue>10</issue>):<fpage>1349</fpage>&#x2013;<lpage>56</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jpsychires.2013.07.002</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">23871450</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC3780783</pub-id>.</mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>Scott-Van Zeeland</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Abrahams</surname> <given-names>BS</given-names></string-name>, <string-name><surname>Alvarez-Retuerto</surname> <given-names>AI</given-names></string-name>, <string-name><surname>Sonnenblick</surname> <given-names>LI</given-names></string-name>, <string-name><surname>Rudie</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Ghahremani</surname> <given-names>D</given-names></string-name>, <etal>et al.</etal> <article-title>Altered functional connectivity in frontal lobe circuits is associated with variation in the autism risk gene CNTNAP2</article-title>. <source>Science translational medicine</source>. <year>2010</year>;<volume>2</volume>(<issue>56</issue>):<fpage>56ra80</fpage>. doi: <pub-id pub-id-type="doi">10.1126/scitranslmed.3001344</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">21048216</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC3065863</pub-id>.</mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>Dennis</surname> <given-names>EL</given-names></string-name>, <string-name><surname>Jahanshad</surname> <given-names>N</given-names></string-name>, <string-name><surname>Rudie</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Brown</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Johnson</surname> <given-names>K</given-names></string-name>, <string-name><surname>McMahon</surname> <given-names>KL</given-names></string-name>, <etal>et al.</etal> <article-title>Altered structural brain connectivity in healthy carriers of the autism risk gene, CNTNAP2</article-title>. <source>Brain Connect</source>. <year>2011</year>;<volume>1</volume>(<issue>6</issue>):<fpage>447</fpage>&#x2013;<lpage>59</lpage>. doi: <pub-id pub-id-type="doi">10.1089/brain.2011.0064</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">22500773</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMCPMC3420970</pub-id>.</mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Tan</surname> <given-names>GC</given-names></string-name>, <string-name><surname>Doke</surname> <given-names>TF</given-names></string-name>, <string-name><surname>Ashburner</surname> <given-names>J</given-names></string-name>, <string-name><surname>Wood</surname> <given-names>NW</given-names></string-name>, <article-title>Frackowiak RS. Normal variation in fronto-occipital circuitry and cerebellar structure with an autism-associated polymorphism of CNTNAP2</article-title>. <source>NeuroImage</source>. <year>2010</year>;<volume>53</volume>(<issue>3</issue>):<fpage>1030</fpage>&#x2013;<lpage>42</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.02.018</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">20176116</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC2941042</pub-id>.</mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><string-name><surname>Udden</surname> <given-names>J</given-names></string-name>, <string-name><surname>Snijders</surname> <given-names>TM</given-names></string-name>, <string-name><surname>Fisher</surname> <given-names>SE</given-names></string-name>, <string-name><surname>Hagoort</surname> <given-names>P.</given-names></string-name> <article-title>A common variant of the CNTNAP2 gene is associated with structural variation in the left superior occipital gyrus</article-title>. <source>Brain and language</source>. <year>2017</year>;<volume>172</volume>:<fpage>16</fpage>&#x2013;<lpage>21</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bandl.2016.02.003</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">27059522</pub-id>.</mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Koeda</surname> <given-names>M</given-names></string-name>, <string-name><surname>Watanabe</surname> <given-names>A</given-names></string-name>, <string-name><surname>Tsuda</surname> <given-names>K</given-names></string-name>, <string-name><surname>Matsumoto</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ikeda</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>W</given-names></string-name>, <etal>et al.</etal> <article-title>Interaction effect between handedness and CNTNAP2 polymorphism (rs7794745 genotype) on voice-specific frontotemporal activity in healthy individuals: an fMRI study</article-title>. <source>Frontiers in behavioral neuroscience</source>. <year>2015</year>;<volume>9</volume>:<fpage>87</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnbeh.2015.00087</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">25941478</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC4403548</pub-id>.</mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Steer</surname> <given-names>CD</given-names></string-name>, <string-name><surname>Golding</surname> <given-names>J</given-names></string-name>, <string-name><surname>Bolton</surname> <given-names>PF.</given-names></string-name> <article-title>Traits contributing to the autistic spectrum</article-title>. <source>PloS one</source>. <year>2010</year>;<volume>5</volume>(<issue>9</issue>):<fpage>e12633</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0012633</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">20838614</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC2935882</pub-id>.</mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Nascimento</surname> <given-names>PP</given-names></string-name>, <string-name><surname>Bossolani-Martins</surname> <given-names>AL</given-names></string-name>, <string-name><surname>Rosan</surname> <given-names>DB</given-names></string-name>, <string-name><surname>Mattos</surname> <given-names>LC</given-names></string-name>, <string-name><surname>Brandao-Mattos</surname> <given-names>C</given-names></string-name>, <string-name><surname>Fett-Conte</surname> <given-names>AC.</given-names></string-name> <article-title>Single nucleotide polymorphisms in the CNTNAP2 gene in Brazilian patients with autistic spectrum disorder</article-title>. <source>Genetics and molecular research : GMR</source>. <year>2016</year>; <volume>15</volume>(<issue>1</issue>). doi: <pub-id pub-id-type="doi">10.4238/gmr.15017422</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">26909962</pub-id>.</mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Chiocchetti</surname> <given-names>AG</given-names></string-name>, <string-name><surname>Kopp</surname> <given-names>M</given-names></string-name>, <string-name><surname>Waltes</surname> <given-names>R</given-names></string-name>, <string-name><surname>Haslinger</surname> <given-names>D</given-names></string-name>, <string-name><surname>Duketis</surname> <given-names>E</given-names></string-name>, <string-name><surname>Jarczok</surname> <given-names>TA</given-names></string-name>, <etal>et al.</etal> <article-title>Variants of the CNTNAP2 5&#x2019; promoter as risk factors for autism spectrum disorders: a genetic and functional approach</article-title>. <source>Molecular psychiatry</source>. <year>2015</year>;<volume>20</volume>(<issue>7</issue>):<fpage>839</fpage>&#x2013;<lpage>49</lpage>. doi: <pub-id pub-id-type="doi">10.1038/mp.2014.103</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">25224256</pub-id>.</mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>Sampath</surname> <given-names>S</given-names></string-name>, <string-name><surname>Bhat</surname> <given-names>S</given-names></string-name>, <string-name><surname>Gupta</surname> <given-names>S</given-names></string-name>, <string-name><surname>O&#x2019;Connor</surname> <given-names>A</given-names></string-name>, <string-name><surname>West</surname> <given-names>AB</given-names></string-name>, <string-name><surname>Arking</surname> <given-names>DE</given-names></string-name>, <etal>et al.</etal> <article-title>Defining the contribution of CNTNAP2 to autism susceptibility</article-title>. <source>PloS one</source>. <year>2013</year>;<volume>8</volume>(<issue>10</issue>):<fpage>e77906</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0077906</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">24147096</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC3798378</pub-id>.</mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Anney</surname> <given-names>R</given-names></string-name>, <string-name><surname>Klei</surname> <given-names>L</given-names></string-name>, <string-name><surname>Pinto</surname> <given-names>D</given-names></string-name>, <string-name><surname>Almeida</surname> <given-names>J</given-names></string-name>, <string-name><surname>Bacchelli</surname> <given-names>E</given-names></string-name>, <string-name><surname>Baird</surname> <given-names>G</given-names></string-name>, <etal>et al.</etal> <article-title>Individual common variants exert weak effects on the risk for autism spectrum disorders</article-title>. <source>Human molecular genetics</source>. <year>2012</year>;<volume>21</volume>(<issue>21</issue>):<fpage>4781</fpage>&#x2013;<lpage>92</lpage>. doi: <pub-id pub-id-type="doi">10.1093/hmg/dds301</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">22843504</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC3471395</pub-id>.</mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Poot</surname> <given-names>M.</given-names></string-name> <article-title>A candidate gene association study further corroborates involvement of contactin genes in autism</article-title>. <source>Molecular syndromology</source>. <year>2014</year>;<volume>5</volume>(<issue>5</issue>):<fpage>229</fpage>&#x2013;<lpage>35</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000362891</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">25337070</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC4188154</pub-id>.</mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Gregor</surname> <given-names>A</given-names></string-name>, <string-name><surname>Albrecht</surname> <given-names>B</given-names></string-name>, <string-name><surname>Bader</surname> <given-names>I</given-names></string-name>, <string-name><surname>Bijlsma</surname> <given-names>EK</given-names></string-name>, <string-name><surname>Ekici</surname> <given-names>AB</given-names></string-name>, <string-name><surname>Engels</surname> <given-names>H</given-names></string-name>, <etal>et al.</etal> <article-title>Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1</article-title>. <source>BMC medical genetics</source>. <year>2011</year>,<volume>12</volume>:<fpage>106</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1471-2350-12-106</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">21827697</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC3162517</pub-id>.</mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="journal"><string-name><surname>Belloso</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Bache</surname> <given-names>I</given-names></string-name>, <string-name><surname>Guitart</surname> <given-names>M</given-names></string-name>, <string-name><surname>Caballin</surname> <given-names>MR</given-names></string-name>, <string-name><surname>Halgren</surname> <given-names>C</given-names></string-name>, <string-name><surname>Kirchhoff</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title>Disruption of the CNTNAP2 gene in a t(7;15) translocation family without symptoms of Gilles de la Tourette syndrome</article-title>. <source>European journal of human genetics : EJHG</source>. <year>2007</year>;<volume>15</volume>(<issue>6</issue>):<fpage>711</fpage>&#x2013;<lpage>3</lpage>. doi: <pub-id pub-id-type="doi">10.1038/sj.ejhg.5201824</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">17392702</pub-id>.</mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Polimanti</surname> <given-names>R</given-names></string-name>, <string-name><surname>Squitti</surname> <given-names>R</given-names></string-name>, <string-name><surname>Pantaleo</surname> <given-names>M</given-names></string-name>, <string-name><surname>Giglio</surname> <given-names>S</given-names></string-name>, <string-name><surname>Zito</surname> <given-names>G.</given-names></string-name> <article-title>Duplication of FOXP2 binding sites within CNTNAP2 gene in a girl with neurodevelopmental delay</article-title>. <source>Minerva pediatrica</source>. <year>2017</year>;<volume>69</volume>(<issue>2</issue>):<fpage>162</fpage>&#x2013;<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.23736/S0026-4946.16.04326-7</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">27215640</pub-id>.</mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Mikhail</surname> <given-names>FM</given-names></string-name>, <string-name><surname>Lose</surname> <given-names>EJ</given-names></string-name>, <string-name><surname>Robin</surname> <given-names>NH</given-names></string-name>, <string-name><surname>Descartes</surname> <given-names>MD</given-names></string-name>, <string-name><surname>Rutledge</surname> <given-names>KD</given-names></string-name>, <string-name><surname>Rutledge</surname> <given-names>SL</given-names></string-name>, <etal>et al.</etal> <article-title>Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disorders</article-title>. <source>American journal of medical genetics Part A</source>. <year>2011</year>;<volume>155A</volume>(<issue>10</issue>):<fpage>2386</fpage>&#x2013;<lpage>96</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ajmg.a.34177</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">22031302</pub-id>.</mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><string-name><surname>Bakkaloglu</surname> <given-names>B</given-names></string-name>, <string-name><surname>O&#x2019;Roak</surname> <given-names>BJ</given-names></string-name>, <string-name><surname>Louvi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Gupta</surname> <given-names>AR</given-names></string-name>, <string-name><surname>Abelson</surname> <given-names>JF</given-names></string-name>, <string-name><surname>Morgan</surname> <given-names>TM</given-names></string-name>, <etal>et al.</etal> <article-title>Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders</article-title>. <source>American journal of human genetics</source>. <year>2008</year>;<volume>82</volume>(<issue>1</issue>):<fpage>165</fpage>&#x2013;<lpage>73</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ajhg.2007.09.017</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">18179895</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC2253974</pub-id>.</mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="journal"><string-name><surname>Poot</surname> <given-names>M</given-names></string-name>, <string-name><surname>Beyer</surname> <given-names>V</given-names></string-name>, <string-name><surname>Schwaab</surname> <given-names>I</given-names></string-name>, <string-name><surname>Damatova</surname> <given-names>N</given-names></string-name>, <string-name><surname>Van&#x2019;t Slot</surname> <given-names>R</given-names></string-name>, <string-name><surname>Prothero</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal> <article-title>Disruption of CNTNAP2 and additional structural genome changes in a boy with speech delay and autism spectrum disorder</article-title>. <source>Neurogenetics</source>. <year>2010</year>;<volume>11</volume>(<issue>1</issue>):<fpage>81</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10048-009-0205-1</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">19582487</pub-id>.</mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>Girirajan</surname> <given-names>S</given-names></string-name>, <string-name><surname>Dennis</surname> <given-names>MY</given-names></string-name>, <string-name><surname>Baker</surname> <given-names>C</given-names></string-name>, <string-name><surname>Malig</surname> <given-names>M</given-names></string-name>, <string-name><surname>Coe</surname> <given-names>BP</given-names></string-name>, <string-name><surname>Campbell</surname> <given-names>CD</given-names></string-name>, <etal>et al.</etal> <article-title>Refinement and discovery of new hotspots of copy-number variation associated with autism spectrum disorder</article-title>. <source>American journal of human genetics</source>. <year>2013</year>;<volume>92</volume>(<issue>2</issue>):<fpage>221</fpage>&#x2013;<lpage>37</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.12.016</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">23375656</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC3567267</pub-id>.</mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>Prasad</surname> <given-names>A</given-names></string-name>, <string-name><surname>Merico</surname> <given-names>D</given-names></string-name>, <string-name><surname>Thiruvahindrapuram</surname> <given-names>B</given-names></string-name>, <string-name><surname>Wei</surname> <given-names>J</given-names></string-name>, <string-name><surname>Lionel</surname> <given-names>AC</given-names></string-name>, <string-name><surname>Sato</surname> <given-names>D</given-names></string-name>, <etal>et al.</etal> <source>A discovery resource of rare copy number variations in individuals with autism spectrum disorder. G3</source>. <year>2012</year>;<volume>2</volume>(<issue>12</issue>):<fpage>1665</fpage>&#x2013;<lpage>85</lpage>. doi: <pub-id pub-id-type="doi">10.1534/g3.112.004689</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">23275889</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC3516488</pub-id>.</mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><string-name><surname>Nord</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Roeb</surname> <given-names>W</given-names></string-name>, <string-name><surname>Dickel</surname> <given-names>DE</given-names></string-name>, <string-name><surname>Walsh</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kusenda</surname> <given-names>M</given-names></string-name>, <string-name><surname>O&#x2019;Connor</surname> <given-names>KL</given-names></string-name>, <etal>et al.</etal> <article-title>Reduced transcript expression of genes affected by inherited and de novo CNVs in autism</article-title>. <source>European journal of human genetics : EJHG</source>. <year>2011</year>;<volume>19</volume>(<issue>6</issue>):<fpage>727</fpage>&#x2013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1038/ejhg.2011.24</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">21448237</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC3110052</pub-id>.</mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="journal"><string-name><surname>Egger</surname> <given-names>G</given-names></string-name>, <string-name><surname>Roetzer</surname> <given-names>KM</given-names></string-name>, <string-name><surname>Noor</surname> <given-names>A</given-names></string-name>, <string-name><surname>Lionel</surname> <given-names>AC</given-names></string-name>, <string-name><surname>Mahmood</surname> <given-names>H</given-names></string-name>, <string-name><surname>Schwarzbraun</surname> <given-names>T</given-names></string-name>, <etal>et al.</etal> <article-title>Identification of risk genes for autism spectrum disorder through copy number variation analysis in Austrian families</article-title>. <source>Neurogenetics</source>. <year>2014</year>;<volume>15</volume>(<issue>2</issue>):<fpage>117</fpage>&#x2013;<lpage>27</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10048-014-0394-0</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">24643514</pub-id>.</mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Vogt</surname> <given-names>D</given-names></string-name>, <string-name><surname>Cho</surname> <given-names>KKA</given-names></string-name>, <string-name><surname>Shelton</surname> <given-names>SM</given-names></string-name>, <string-name><surname>Paul</surname> <given-names>A</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>ZJ</given-names></string-name>, <string-name><surname>Sohal</surname> <given-names>VS</given-names></string-name>, <etal>et al.</etal> <article-title>Mouse Cntnap2 and Human CNTNAP2 ASD Alleles Cell Autonomously Regulate PV&#x002B; Cortical Interneurons</article-title>. <source>Cerebral cortex</source>. <year>2017</year>:<fpage>112</fpage>. doi: <pub-id pub-id-type="doi">10.1093/cercor/bhx248</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">29028946</pub-id>.</mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><string-name><surname>Scott</surname> <given-names>R</given-names></string-name>, <string-name><surname>Sanchez-Aguilera</surname> <given-names>A</given-names></string-name>, <string-name><surname>van Elst</surname> <given-names>K</given-names></string-name>, <string-name><surname>Lim</surname> <given-names>L</given-names></string-name>, <string-name><surname>Dehorter</surname> <given-names>N</given-names></string-name>, <string-name><surname>Bae</surname> <given-names>SE</given-names></string-name>, <etal>et al.</etal> <article-title>Loss of Cntnap2 Causes Axonal Excitability Deficits, Developmental Delay in Cortical Myelination, and Abnormal Stereotyped Motor Behavior</article-title>. <source>Cerebral cortex</source>. <year>2017</year>. doi: <pub-id pub-id-type="doi">10.1093/cercor/bhx341</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">29300891</pub-id>.</mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname> <given-names>KS</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>XF</given-names></string-name>, <string-name><surname>Aragam</surname> <given-names>N.</given-names></string-name> <article-title>A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder</article-title>. <source>Schizophrenia research</source>. <year>2010</year>;<volume>124</volume>(<issue>1-3</issue>):<fpage>192</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.schres.2010.09.002</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">20889312</pub-id>.</mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Zhong</surname> <given-names>X</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>H.</given-names></string-name> <article-title>Linkage analysis and association analysis in the presence of linkage using age at onset of COGA alcoholism data</article-title>. <source>BMC genetics</source>. <year>2005</year>,<volume>6</volume> Suppl <issue>1</issue>:<fpage>S31</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1471-2156-6-S1-S31</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">16451641</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC1866754</pub-id>.</mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><string-name><surname>Terracciano</surname> <given-names>A</given-names></string-name>, <string-name><surname>Sanna</surname> <given-names>S</given-names></string-name>, <string-name><surname>Uda</surname> <given-names>M</given-names></string-name>, <string-name><surname>Deiana</surname> <given-names>B</given-names></string-name>, <string-name><surname>Usala</surname> <given-names>G</given-names></string-name>, <string-name><surname>Busonero</surname> <given-names>F</given-names></string-name>, <etal>et al.</etal> <article-title>Genome-wide association scan for five major dimensions of personality</article-title>. <source>Molecular psychiatry</source>. <year>2010</year>;<volume>15</volume>(<issue>6</issue>):<fpage>647</fpage>&#x2013;<lpage>56</lpage>. doi: <pub-id pub-id-type="doi">10.1038/mp.2008.113</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">18957941</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC2874623</pub-id>.</mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Wray</surname> <given-names>NR</given-names></string-name>, <string-name><surname>Pergadia</surname> <given-names>ML</given-names></string-name>, <string-name><surname>Blackwood</surname> <given-names>DH</given-names></string-name>, <string-name><surname>Penninx</surname> <given-names>BW</given-names></string-name>, <string-name><surname>Gordon</surname> <given-names>SD</given-names></string-name>, <string-name><surname>Nyholt</surname> <given-names>DR</given-names></string-name>, <etal>et al.</etal> <article-title>Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned</article-title>. <source>Molecular psychiatry</source>. <year>2012</year>;<volume>17</volume>(<issue>1</issue>):<fpage>36</fpage>&#x2013;<lpage>48</lpage>. doi: <pub-id pub-id-type="doi">10.1038/mp.2010.109</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">21042317</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC3252611</pub-id>.</mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Chen</surname> <given-names>X</given-names></string-name>, <string-name><surname>Long</surname> <given-names>F</given-names></string-name>, <string-name><surname>Cai</surname> <given-names>B</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>X</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>G.</given-names></string-name> <article-title>A novel relationship for schizophrenia, bipolar and major depressive disorder Part 7: A hint from chromosome 7 high density association screen</article-title>. <source>Behavioural brain research</source>. <year>2015</year>;<volume>293</volume>:<fpage>241</fpage>&#x2013;<lpage>51</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbr.2015.06.043</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">26192912</pub-id>.</mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>Newbury</surname> <given-names>DF</given-names></string-name>, <string-name><surname>Paracchini</surname> <given-names>S</given-names></string-name>, <string-name><surname>Scerri</surname> <given-names>TS</given-names></string-name>, <string-name><surname>Winchester</surname> <given-names>L</given-names></string-name>, <string-name><surname>Addis</surname> <given-names>L</given-names></string-name>, <string-name><surname>Richardson</surname> <given-names>AJ</given-names></string-name>, <etal>et al.</etal> <article-title>Investigation of dyslexia and SLI risk variants in reading- and language-impaired subjects</article-title>. <source>Behavior genetics</source>. <year>2011</year>;<volume>41</volume>(<issue>1</issue>):<fpage>90</fpage>&#x2013;<lpage>104</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10519-010-9424-3</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">21165691</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC3029677</pub-id>.</mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="journal"><string-name><surname>Peter</surname> <given-names>B</given-names></string-name>, <string-name><surname>Raskind</surname> <given-names>WH</given-names></string-name>, <string-name><surname>Matsushita</surname> <given-names>M</given-names></string-name>, <string-name><surname>Lisowski</surname> <given-names>M</given-names></string-name>, <string-name><surname>Vu</surname> <given-names>T</given-names></string-name>, <string-name><surname>Berninger</surname> <given-names>VW</given-names></string-name>, <etal>et al.</etal> <article-title>Replication of CNTNAP2 association with nonword repetition and support for FOXP2 association with timed reading and motor activities in a dyslexia family sample</article-title>. <source>Journal of neurodevelopmental disorders</source>. <year>2011</year>;<volume>3</volume>(<issue>1</issue>):<fpage>39</fpage>&#x2013;<lpage>49</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11689-010-9065-0</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">21484596</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC3163991</pub-id>.</mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Stein</surname> <given-names>MB</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>BZ</given-names></string-name>, <string-name><surname>Chavira</surname> <given-names>DA</given-names></string-name>, <string-name><surname>Hitchcock</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Sung</surname> <given-names>SC</given-names></string-name>, <string-name><surname>Shipon-Blum</surname> <given-names>E</given-names></string-name>, <etal>et al.</etal> <article-title>A common genetic variant in the neurexin superfamily member CNTNAP2 is associated with increased risk for selective mutism and social anxiety-related traits</article-title>. <source>Biological psychiatry</source>. <year>2011</year>;<volume>69</volume>(<issue>9</issue>):<fpage>825</fpage>&#x2013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biopsych.2010.11.008</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">21193173</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC3079072</pub-id>.</mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="journal"><string-name><surname>Ji</surname> <given-names>W</given-names></string-name>, <string-name><surname>Li</surname> <given-names>T</given-names></string-name>, <string-name><surname>Pan</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Tao</surname> <given-names>H</given-names></string-name>, <string-name><surname>Ju</surname> <given-names>K</given-names></string-name>, <string-name><surname>Wen</surname> <given-names>Z</given-names></string-name>, <etal>et al.</etal> <article-title>CNTNAP2 is significantly associated with schizophrenia and major depression in the Han Chinese population</article-title>. <source>Psychiatry research</source>. <year>2013</year>;<volume>207</volume>(<issue>3</issue>):<fpage>225</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.psychres.2012.09.024</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">23123147</pub-id>.</mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Zhao</surname> <given-names>YJ</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>YP</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>WZ</given-names></string-name>, <string-name><surname>Sun</surname> <given-names>HW</given-names></string-name>, <string-name><surname>Ma</surname> <given-names>HW</given-names></string-name>, <string-name><surname>Zhao</surname> <given-names>YR.</given-names></string-name> <article-title>CNTNAP2 Is Significantly Associated With Speech Sound Disorder in the Chinese Han Population</article-title>. <source>Journal of child neurology</source>. <year>2015</year>;<volume>30</volume>(<issue>13</issue>):<fpage>1806</fpage>&#x2013;<lpage>11</lpage>. doi: <pub-id pub-id-type="doi">10.1177/0883073815581609</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">25895914</pub-id>.</mixed-citation></ref>
<ref id="c51"><label>51.</label><mixed-citation publication-type="journal"><string-name><surname>Friedman</surname> <given-names>JI</given-names></string-name>, <string-name><surname>Vrijenhoek</surname> <given-names>T</given-names></string-name>, <string-name><surname>Markx</surname> <given-names>S</given-names></string-name>, <string-name><surname>Janssen</surname> <given-names>IM</given-names></string-name>, <string-name><surname>van der Vliet</surname> <given-names>WA</given-names></string-name>, <string-name><surname>Faas</surname> <given-names>BH</given-names></string-name>, <etal>et al.</etal> <article-title>CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy</article-title>. <source>Molecular psychiatry</source>. <year>2008</year>;<volume>13</volume>(<issue>3</issue>):<fpage>261</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1038/sj.mp.4002049</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">17646849</pub-id>.</mixed-citation></ref>
<ref id="c52"><label>52.</label><mixed-citation publication-type="journal"><string-name><surname>Malhotra</surname> <given-names>D</given-names></string-name>, <string-name><surname>McCarthy</surname> <given-names>S</given-names></string-name>, <string-name><surname>Michaelson</surname> <given-names>JJ</given-names></string-name>, <string-name><surname>Vacic</surname> <given-names>V</given-names></string-name>, <string-name><surname>Burdick</surname> <given-names>KE</given-names></string-name>, <string-name><surname>Yoon</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> <article-title>High frequencies of de novo CNVs in bipolar disorder and schizophrenia</article-title>. <source>Neuron</source>. <year>2011</year>;<volume>72</volume>(<issue>6</issue>):<fpage>951</fpage>&#x2013;<lpage>63</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuron.2011.11.007</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">22196331</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC3921625</pub-id>.</mixed-citation></ref>
<ref id="c53"><label>53.</label><mixed-citation publication-type="journal"><string-name><surname>Zhang</surname> <given-names>D</given-names></string-name>, <string-name><surname>Cheng</surname> <given-names>L</given-names></string-name>, <string-name><surname>Qian</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Alliey-Rodriguez</surname> <given-names>N</given-names></string-name>, <string-name><surname>Kelsoe</surname> <given-names>JR</given-names></string-name>, <string-name><surname>Greenwood</surname> <given-names>T</given-names></string-name>, <etal>et al.</etal> <article-title>Singleton deletions throughout the genome increase risk of bipolar disorder</article-title>. <source>Molecular psychiatry</source>. <year>2009</year>;<volume>14</volume>(<issue>4</issue>):<fpage>376</fpage>&#x2013;<lpage>80</lpage>. doi: <pub-id pub-id-type="doi">10.1038/mp.2008.144</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">19114987</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC2735188</pub-id>.</mixed-citation></ref>
<ref id="c54"><label>54.</label><mixed-citation publication-type="journal"><string-name><surname>Lee</surname> <given-names>IS</given-names></string-name>, <string-name><surname>Carvalho</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Douvaras</surname> <given-names>P</given-names></string-name>, <string-name><surname>Ho</surname> <given-names>SM</given-names></string-name>, <string-name><surname>Hartley</surname> <given-names>BJ</given-names></string-name>, <string-name><surname>Zuccherato</surname> <given-names>LW</given-names></string-name>, <etal>et al.</etal> <article-title>Characterization of molecular and cellular phenotypes associated with a heterozygous CNTNAP2 deletion using patient-derived hiPSC neural cells</article-title>. <source>NPJ schizophrenia</source>. <year>2015</year>;<fpage>1</fpage>. PubMed PMID: <pub-id pub-id-type="pmid">26985448</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC4789165</pub-id>.</mixed-citation></ref>
<ref id="c55"><label>55.</label><mixed-citation publication-type="journal"><string-name><surname>Elia</surname> <given-names>J</given-names></string-name>, <string-name><surname>Gai</surname> <given-names>X</given-names></string-name>, <string-name><surname>Xie</surname> <given-names>HM</given-names></string-name>, <string-name><surname>Perin</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Geiger</surname> <given-names>E</given-names></string-name>, <string-name><surname>Glessner</surname> <given-names>JT</given-names></string-name>, <etal>et al.</etal> <article-title>Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes</article-title>. <source>Molecular psychiatry</source>. <year>2010</year>;<volume>15</volume>(<issue>6</issue>):<fpage>637</fpage>&#x2013;<lpage>46</lpage>. doi: <pub-id pub-id-type="doi">10.1038/mp.2009.57</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">19546859</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC2877197</pub-id>.</mixed-citation></ref>
<ref id="c56"><label>56.</label><mixed-citation publication-type="journal"><string-name><surname>Mefford</surname> <given-names>HC</given-names></string-name>, <string-name><surname>Muhle</surname> <given-names>H</given-names></string-name>, <string-name><surname>Ostertag</surname> <given-names>P</given-names></string-name>, <string-name><surname>von Spiczak</surname> <given-names>S</given-names></string-name>, <string-name><surname>Buysse</surname> <given-names>K</given-names></string-name>, <string-name><surname>Baker</surname> <given-names>C</given-names></string-name>, <etal>et al.</etal> <article-title>Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies</article-title>. <source>PLoS genetics</source>. <year>2010</year>;<volume>6</volume>(<issue>5</issue>):<fpage>e1000962</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pgen.1000962</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">20502679</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC2873910</pub-id>.</mixed-citation></ref>
<ref id="c57"><label>57.</label><mixed-citation publication-type="journal"><string-name><surname>Lesca</surname> <given-names>G</given-names></string-name>, <string-name><surname>Rudolf</surname> <given-names>G</given-names></string-name>, <string-name><surname>Labalme</surname> <given-names>A</given-names></string-name>, <string-name><surname>Hirsch</surname> <given-names>E</given-names></string-name>, <string-name><surname>Arzimanoglou</surname> <given-names>A</given-names></string-name>, <string-name><surname>Genton</surname> <given-names>P</given-names></string-name>, <etal>et al.</etal> <article-title>Epileptic encephalopathies of the Landau-Kleffner and continuous spike and waves during slow-wave sleep types: genomic dissection makes the link with autism</article-title>. <source>Epilepsia</source>. <year>2012</year>;<volume>53</volume>(<issue>9</issue>):<fpage>1526</fpage>&#x2013;<lpage>38</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1528-1167.2012.03559.x</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">22738016</pub-id>.</mixed-citation></ref>
<ref id="c58"><label>58.</label><mixed-citation publication-type="journal"><string-name><surname>Curran</surname> <given-names>S</given-names></string-name>, <string-name><surname>Ahn</surname> <given-names>JW</given-names></string-name>, <string-name><surname>Grayton</surname> <given-names>H</given-names></string-name>, <string-name><surname>Collier</surname> <given-names>DA</given-names></string-name>, <string-name><surname>Ogilvie</surname> <given-names>CM.</given-names></string-name> <article-title>NRXN1 deletions identified by array comparative genome hybridisation in a clinical case series - further understanding of the relevance of NRXN1 to neurodevelopmental disorders</article-title>. <source>Journal of molecular psychiatry</source>. <year>2013</year>;<volume>1</volume>(<issue>1</issue>):<fpage>4</fpage>. doi: <pub-id pub-id-type="doi">10.1186/2049-9256-1-4</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">25408897</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC4223877</pub-id>.</mixed-citation></ref>
<ref id="c59"><label>59.</label><mixed-citation publication-type="journal"><string-name><surname>Pippucci</surname> <given-names>T</given-names></string-name>, <string-name><surname>Licchetta</surname> <given-names>L</given-names></string-name>, <string-name><surname>Baldassari</surname> <given-names>S</given-names></string-name>, <string-name><surname>Palombo</surname> <given-names>F</given-names></string-name>, <string-name><surname>Menghi</surname> <given-names>V</given-names></string-name>, <string-name><surname>D&#x2019;Aurizio</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal> <article-title>Epilepsy with auditory features: A heterogeneous clinico-molecular disease</article-title>. <source>Neurology Genetics</source>. <year>2015</year>;<volume>1</volume>(<issue>1</issue>):<fpage>e5</fpage>. doi: <pub-id pub-id-type="doi">10.1212/NXG.0000000000000005</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">27066544</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC4821078</pub-id>.</mixed-citation></ref>
<ref id="c60"><label>60.</label><mixed-citation publication-type="journal"><string-name><surname>Verkerk</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Mathews</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Joosse</surname> <given-names>M</given-names></string-name>, <string-name><surname>Eussen</surname> <given-names>BH</given-names></string-name>, <string-name><surname>Heutink</surname> <given-names>P</given-names></string-name>, <string-name><surname>Oostra</surname> <given-names>BA</given-names></string-name>, <etal>et al.</etal> <article-title>CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder</article-title>. <source>Genomics</source>. <year>2003</year>;<volume>82</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>9</lpage>. PubMed PMID: <pub-id pub-id-type="pmid">12809671</pub-id>.</mixed-citation></ref>
<ref id="c61"><label>61.</label><mixed-citation publication-type="journal"><string-name><surname>Hoyer</surname> <given-names>H</given-names></string-name>, <string-name><surname>Braathen</surname> <given-names>GJ</given-names></string-name>, <string-name><surname>Eek</surname> <given-names>AK</given-names></string-name>, <string-name><surname>Nordang</surname> <given-names>GB</given-names></string-name>, <string-name><surname>Skjelbred</surname> <given-names>CF</given-names></string-name>, <string-name><surname>Russell</surname> <given-names>MB.</given-names></string-name> <article-title>Copy number variations in a population-based study of Charcot-Marie-Tooth disease</article-title>. <source>BioMed research international</source>. <year>2015</year>;<volume>2015</volume>:<fpage>960404</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2015/960404</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">25648254</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC4306395</pub-id>.</mixed-citation></ref>
<ref id="c62"><label>62.</label><mixed-citation publication-type="journal"><string-name><surname>Al-Murrani</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ashton</surname> <given-names>F</given-names></string-name>, <string-name><surname>Aftimos</surname> <given-names>S</given-names></string-name>, <string-name><surname>George</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Love</surname> <given-names>DR.</given-names></string-name> <article-title>Amino-Terminal Microdeletion within the CNTNAP2 Gene Associated with Variable Expressivity of Speech Delay</article-title>. <source>Case reports in genetics</source>. <year>2012</year>;<volume>2012</volume>:<fpage>172408</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2012/172408</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">23074684</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC3447220</pub-id>.</mixed-citation></ref>
<ref id="c63"><label>63.</label><mixed-citation publication-type="journal"><string-name><surname>Centanni</surname> <given-names>TM</given-names></string-name>, <string-name><surname>Sanmann</surname> <given-names>JN</given-names></string-name>, <string-name><surname>Green</surname> <given-names>JR</given-names></string-name>, <string-name><surname>Iuzzini-Seigel</surname> <given-names>J</given-names></string-name>, <string-name><surname>Bartlett</surname> <given-names>C</given-names></string-name>, <string-name><surname>Sanger</surname> <given-names>WG</given-names></string-name>, <etal>et al.</etal> <article-title>The role of candidate-gene CNTNAP2 in childhood apraxia of speech and specific language impairment</article-title>. <source>American journal of medical genetics Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</source>. <year>2015</year>;<volume>168</volume>(<issue>7</issue>):<fpage>536</fpage>&#x2013;<lpage>43</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ajmg.b.32325</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">26097074</pub-id>.</mixed-citation></ref>
<ref id="c64"><label>64.</label><mixed-citation publication-type="journal"><string-name><surname>Laffin</surname> <given-names>JJ</given-names></string-name>, <string-name><surname>Raca</surname> <given-names>G</given-names></string-name>, <string-name><surname>Jackson</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Strand</surname> <given-names>EA</given-names></string-name>, <string-name><surname>Jakielski</surname> <given-names>KJ</given-names></string-name>, <string-name><surname>Shriberg</surname> <given-names>LD.</given-names></string-name> <article-title>Novel candidate genes and regions for childhood apraxia of speech identified by array comparative genomic hybridization</article-title>. <source>Genetics in medicine : official journal of the American College of Medical Genetics</source>. <year>2012</year>;<volume>14</volume>(<issue>11</issue>):<fpage>928</fpage>&#x2013;<lpage>36</lpage>. doi: <pub-id pub-id-type="doi">10.1038/gim.2012.72</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">22766611</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC3563158</pub-id>.</mixed-citation></ref>
<ref id="c65"><label>65.</label><mixed-citation publication-type="journal"><string-name><surname>Veerappa</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Saldanha</surname> <given-names>M</given-names></string-name>, <string-name><surname>Padakannaya</surname> <given-names>P</given-names></string-name>, <string-name><surname>Ramachandra</surname> <given-names>NB.</given-names></string-name> <article-title>Family-based genome-wide copy number scan identifies five new genes of dyslexia involved in dendritic spinal plasticity</article-title>. <source>Journal of human genetics</source>. <year>2013</year>;<volume>58</volume>(<issue>8</issue>):<fpage>539</fpage>&#x2013;<lpage>47</lpage>. doi: <pub-id pub-id-type="doi">10.1038/jhg.2013.47</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">23677055</pub-id>.</mixed-citation></ref>
<ref id="c66"><label>66.</label><mixed-citation publication-type="journal"><string-name><surname>Toma</surname> <given-names>C</given-names></string-name>, <string-name><surname>Shaw</surname> <given-names>AD</given-names></string-name>, <string-name><surname>Allcock</surname> <given-names>RJN</given-names></string-name>, <string-name><surname>Heath</surname> <given-names>A</given-names></string-name>, <string-name><surname>Pierce</surname> <given-names>KD</given-names></string-name>, <string-name><surname>Mitchell</surname> <given-names>PB</given-names></string-name>, <etal>et al.</etal> <article-title>An examination of multiple classes of rare variants in extended families with bipolar disorder</article-title>. <source>Translational psychiatry</source>. <year>2018</year>;<volume>8</volume>(<issue>1</issue>):<fpage>65</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41398-018-0113-y</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">29531218</pub-id>.</mixed-citation></ref>
<ref id="c67"><label>67.</label><mixed-citation publication-type="journal"><string-name><surname>Fromer</surname> <given-names>M</given-names></string-name>, <string-name><surname>Pocklington</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Kavanagh</surname> <given-names>DH</given-names></string-name>, <string-name><surname>Williams</surname> <given-names>HJ</given-names></string-name>, <string-name><surname>Dwyer</surname> <given-names>S</given-names></string-name>, <string-name><surname>Gormley</surname> <given-names>P</given-names></string-name>, <etal>et al.</etal> <article-title>De novo mutations in schizophrenia implicate synaptic networks</article-title>. <source>Nature</source>. <year>2014</year>;<volume>506</volume>(<issue>7487</issue>):<fpage>179</fpage>&#x2013;<lpage>84</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature12929</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">24463507</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC4237002</pub-id>.</mixed-citation></ref>
<ref id="c68"><label>68.</label><mixed-citation publication-type="journal"><string-name><surname>Huang</surname> <given-names>N</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>I</given-names></string-name>, <string-name><surname>Marcotte</surname> <given-names>EM</given-names></string-name>, <string-name><surname>Hurles</surname> <given-names>ME.</given-names></string-name> <article-title>Characterising and predicting haploinsufficiency in the human genome</article-title>. <source>PLoS genetics</source>. <year>2010</year>;<volume>6</volume>(<issue>10</issue>):<fpage>e1001154</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pgen.1001154</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">20976243</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC2954820</pub-id>.</mixed-citation></ref>
<ref id="c69"><label>69.</label><mixed-citation publication-type="journal"><string-name><surname>Ross</surname> <given-names>LA</given-names></string-name>, <string-name><surname>Del Bene</surname> <given-names>VA</given-names></string-name>, <string-name><surname>Molholm</surname> <given-names>S</given-names></string-name>, <string-name><surname>Jae Woo</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Andrade</surname> <given-names>GN</given-names></string-name>, <string-name><surname>Abrahams</surname> <given-names>BS</given-names></string-name>, <etal>et al.</etal> <article-title>Common variation in the autism risk gene CNTNAP2, brain structural connectivity and multisensory speech integration</article-title>. <source>Brain and language</source>. <year>2017</year>;<volume>174</volume>:<fpage>50</fpage>&#x2013;<lpage>60</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bandl.2017.07.005</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">28738218</pub-id>.</mixed-citation></ref>
<ref id="c70"><label>70.</label><mixed-citation publication-type="journal"><string-name><surname>Toma</surname> <given-names>C</given-names></string-name>, <string-name><surname>Hervas</surname> <given-names>A</given-names></string-name>, <string-name><surname>Torrico</surname> <given-names>B</given-names></string-name>, <string-name><surname>Balmana</surname> <given-names>N</given-names></string-name>, <string-name><surname>Salgado</surname> <given-names>M</given-names></string-name>, <string-name><surname>Maristany</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title>Analysis of two language-related genes in autism: a case-control association study of FOXP2 and CNTNAP2</article-title>. <source>Psychiatric genetics</source>. <year>2013</year>;<volume>23</volume>(<issue>2</issue>):<fpage>82</fpage>&#x2013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1097/YPG.0b013e32835d6fc6</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">23277129</pub-id>.</mixed-citation></ref>
<ref id="c71"><label>71.</label><mixed-citation publication-type="journal"><string-name><surname>Werling</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Bobrowski</surname> <given-names>E</given-names></string-name>, <string-name><surname>Taurines</surname> <given-names>R</given-names></string-name>, <string-name><surname>Gundelfinger</surname> <given-names>R</given-names></string-name>, <string-name><surname>Romanos</surname> <given-names>M</given-names></string-name>, <string-name><surname>Grunblatt</surname> <given-names>E</given-names></string-name>, <etal>et al.</etal> <article-title>CNTNAP2 gene in high functioning autism: no association according to family and meta-analysis approaches</article-title>. <source>J Neural Transm (Vienna)</source>. <year>2016</year>;<volume>123</volume>(<issue>3</issue>):<fpage>353</fpage>&#x2013;<lpage>63</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00702-015-1458-5</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">26559825</pub-id>.</mixed-citation></ref>
<ref id="c72"><label>72.</label><mixed-citation publication-type="journal"><string-name><surname>Torrico</surname> <given-names>B</given-names></string-name>, <string-name><surname>Chiocchetti</surname> <given-names>AG</given-names></string-name>, <string-name><surname>Bacchelli</surname> <given-names>E</given-names></string-name>, <string-name><surname>Trabetti</surname> <given-names>E</given-names></string-name>, <string-name><surname>Hervas</surname> <given-names>A</given-names></string-name>, <string-name><surname>Franke</surname> <given-names>B</given-names></string-name>, <etal>et al.</etal> <article-title>Lack of replication of previous autism spectrum disorder GWAS hits in European populations</article-title>. <source>Autism Res</source>. <year>2017</year>;<volume>10</volume>(<issue>2</issue>):<fpage>202</fpage>&#x2013;<lpage>11</lpage>. doi: <pub-id pub-id-type="doi">10.1002/aur.1662</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">27417655</pub-id>.</mixed-citation></ref>
<ref id="c73"><label>73.</label><mixed-citation publication-type="journal"><string-name><surname>Murdoch</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Gupta</surname> <given-names>AR</given-names></string-name>, <string-name><surname>Sanders</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Walker</surname> <given-names>MF</given-names></string-name>, <string-name><surname>Keaney</surname> <given-names>J</given-names></string-name>, <string-name><surname>Fernandez</surname> <given-names>TV</given-names></string-name>, <etal>et al.</etal> <article-title>No evidence for association of autism with rare heterozygous point mutations in Contactin-Associated Protein-Like 2 (CNTNAP2), or in Other Contactin-Associated Proteins or Contactins</article-title>. <source>PLoS genetics</source>. <year>2015</year>;<volume>11</volume>(<issue>1</issue>):<fpage>e1004852</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pgen.1004852</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">25621974</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC4306541</pub-id>.</mixed-citation></ref>
<ref id="c74"><label>74.</label><mixed-citation publication-type="journal"><string-name><surname>Canali</surname> <given-names>G</given-names></string-name>, <string-name><surname>Garcia</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hivert</surname> <given-names>B</given-names></string-name>, <string-name><surname>Pinatel</surname> <given-names>D</given-names></string-name>, <string-name><surname>Goullancourt</surname> <given-names>A</given-names></string-name>, <string-name><surname>Oguievetskaia</surname> <given-names>K</given-names></string-name>, <etal>et al.</etal> <article-title>Genetic variants in autism-related CNTNAP2 impair axonal growth of cortical neurons</article-title>. <source>Human molecular genetics</source>. <year>2018</year>;<volume>27</volume>(<issue>11</issue>):<fpage>1941</fpage>&#x2013;<lpage>54</lpage>. doi: <pub-id pub-id-type="doi">10.1093/hmg/ddy102</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">29788201</pub-id>.</mixed-citation></ref>
<ref id="c75"><label>75.</label><mixed-citation publication-type="journal"><string-name><surname>Adams</surname> <given-names>LJ</given-names></string-name>, <string-name><surname>Mitchell</surname> <given-names>PB</given-names></string-name>, <string-name><surname>Fielder</surname> <given-names>SL</given-names></string-name>, <string-name><surname>Rosso</surname> <given-names>A</given-names></string-name>, <string-name><surname>Donald</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Schofield</surname> <given-names>PR.</given-names></string-name> <article-title>A susceptibility locus for bipolar affective disorder on chromosome 4q35</article-title>. <source>Am J Hum Genet</source>. <year>1998</year>;<volume>62</volume>(<issue>5</issue>):<fpage>1084</fpage>&#x2013;<lpage>91</lpage>. PubMed PMID: <pub-id pub-id-type="pmid">9545396</pub-id>.</mixed-citation></ref>
<ref id="c76"><label>76.</label><mixed-citation publication-type="journal"><string-name><surname>Badenhop</surname> <given-names>RF</given-names></string-name>, <string-name><surname>Moses</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Scimone</surname> <given-names>A</given-names></string-name>, <string-name><surname>Adams</surname> <given-names>LJ</given-names></string-name>, <string-name><surname>Kwok</surname> <given-names>JB</given-names></string-name>, <string-name><surname>Jones</surname> <given-names>AM</given-names></string-name>, <etal>et al.</etal> <article-title>Genetic refinement and physical mapping of a 2.3 Mb probable disease region associated with a bipolar affective disorder susceptibility locus on chromosome 4q35</article-title>. <source>Am J Med Genet B Neuropsychiatr Genet</source>. <year>2003</year>;<volume>117</volume>(<issue>1</issue>):<fpage>23</fpage>&#x2013;<lpage>32</lpage>. PubMed PMID: <pub-id pub-id-type="pmid">12555231</pub-id>.</mixed-citation></ref>
<ref id="c77"><label>77.</label><mixed-citation publication-type="journal"><string-name><surname>Fullerton</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Donald</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Mitchell</surname> <given-names>PB</given-names></string-name>, <string-name><surname>Schofield</surname> <given-names>PR.</given-names></string-name> <article-title>Two-Dimensional Genome Scan Identifies Multiple Genetic Interactions in Bipolar Affective Disorder</article-title>. <source>Biol Psychiatry</source>. <year>2010</year>;<volume>67</volume>(<issue>5</issue>):<fpage>478</fpage>&#x2013;<lpage>86</lpage>. PubMed PMID: <pub-id pub-id-type="pmid">20022591</pub-id>.</mixed-citation></ref>
<ref id="c78"><label>78.</label><mixed-citation publication-type="journal"><string-name><surname>Fullerton</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Badenhop</surname> <given-names>RF</given-names></string-name>, <string-name><surname>Scimone</surname> <given-names>A</given-names></string-name>, <string-name><surname>Blair</surname> <given-names>IP</given-names></string-name>, <string-name><surname>Van Herten</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title>Genome screen of 15 Australian bipolar affective disorder pedigrees supports previously identified loci for bipolar susceptibility genes</article-title>. <source>Psychiatr Genet</source>. <year>2008</year>;<volume>18</volume>(<issue>4</issue>):<fpage>156</fpage>&#x2013;<lpage>61</lpage>. doi: <pub-id pub-id-type="doi">10.1097/YPG.0b013e3282fa1861</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">18628676</pub-id>.</mixed-citation></ref>
<ref id="c79"><label>79.</label><mixed-citation publication-type="journal"><string-name><surname>McAuley</surname> <given-names>EZ</given-names></string-name>, <string-name><surname>Blair</surname> <given-names>IP</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Fullerton</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Scimone</surname> <given-names>A</given-names></string-name>, <string-name><surname>Van Herten</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title>A genome screen of 35 bipolar affective disorder pedigrees provides significant evidence for a susceptibility locus on chromosome 15q25-26</article-title>. <source>Mol Psychiatry</source>. <year>2009</year>;<volume>14</volume>(<issue>5</issue>):<fpage>492</fpage>&#x2013;<lpage>500</lpage>. PubMed PMID: <pub-id pub-id-type="pmid">18227837</pub-id>.</mixed-citation></ref>
<ref id="c80"><label>80.</label><mixed-citation publication-type="book"><chapter-title>National Institute of Mental Health</chapter-title>. <source>NIMH Genetics Initiative: Family Interview for Genetic Studies (FIGS)</source>. <publisher-loc>Rockville, MD</publisher-loc> <year>1992</year>.</mixed-citation></ref>
<ref id="c81"><label>81.</label><mixed-citation publication-type="journal"><string-name><surname>Nurnberger</surname> <given-names>JI</given-names>, <suffix>Jr.</suffix></string-name>, <string-name><surname>Blehar</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Kaufmann</surname> <given-names>CA</given-names></string-name>, <string-name><surname>York-Cooler</surname> <given-names>C</given-names></string-name>, <string-name><surname>Simpson</surname> <given-names>SG</given-names></string-name>, <string-name><surname>Harkavy-Friedman</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal> <article-title>Diagnostic interview for genetic studies. Rationale, unique features, and training</article-title>. <source>NIMH Genetics Initiative. Archives of general psychiatry</source>. <year>1994</year>;<volume>51</volume>(<issue>11</issue>):<fpage>849</fpage>&#x2013;<lpage>59</lpage>; discussion 63-4. PubMed PMID: <pub-id pub-id-type="pmid">7944874</pub-id>.</mixed-citation></ref>
<ref id="c82"><label>82.</label><mixed-citation publication-type="journal"><string-name><surname>de Leeuw</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Mooij</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Heskes</surname> <given-names>T</given-names></string-name>, <string-name><surname>Posthuma</surname> <given-names>D.</given-names></string-name> <article-title>MAGMA: generalized gene-set analysis of GWAS data</article-title>. <source>PLoS computational biology</source>. <year>2015</year>;<volume>11</volume>(<issue>4</issue>):<fpage>e1004219</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pcbi.1004219</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">25885710</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC4401657</pub-id>.</mixed-citation></ref>
<ref id="c83"><label>83.</label><mixed-citation publication-type="journal"><string-name><surname>Demontis</surname> <given-names>D</given-names></string-name>, <string-name><surname>Walters</surname> <given-names>RK</given-names></string-name>, <string-name><surname>Martin</surname> <given-names>J</given-names></string-name>, <string-name><surname>Mattheisen</surname> <given-names>M</given-names></string-name>, <string-name><surname>Als</surname> <given-names>TD</given-names></string-name>, <string-name><surname>Agerbo</surname> <given-names>E</given-names></string-name>, <etal>et al.</etal> <article-title>Discovery Of The First Genome-Wide Significant Risk Loci For ADHD</article-title>. <source>bioRxiv.</source> <year>2017</year>. doi: <pub-id pub-id-type="doi">10.1101/145581</pub-id>.</mixed-citation></ref>
<ref id="c84"><label>84.</label><mixed-citation publication-type="journal"><article-title>Autism Spectrum Disorders Working Group of The Psychiatric Genomics C. Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia</article-title>. <source>Molecular autism</source>. <year>2017</year>;<volume>8</volume>:<fpage>21</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13229-017-0137-9</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">28540026</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC5441062</pub-id>.</mixed-citation></ref>
<ref id="c85"><label>85.</label><mixed-citation publication-type="journal"><collab>Major Depressive Disorder Working Group of the Psychiatric GC</collab>, <string-name><surname>Ripke</surname> <given-names>S</given-names></string-name>, <string-name><surname>Wray</surname> <given-names>NR</given-names></string-name>, <string-name><surname>Lewis</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Hamilton</surname> <given-names>SP</given-names></string-name>, <string-name><surname>Weissman</surname> <given-names>MM</given-names></string-name>, <etal>et al.</etal> <article-title>A mega-analysis of genome-wide association studies for major depressive disorder</article-title>. <source>Molecular psychiatry</source>. <year>2013</year>;<volume>18</volume>(<issue>4</issue>):<fpage>497</fpage>&#x2013;<lpage>511</lpage>. doi: <pub-id pub-id-type="doi">10.1038/mp.2012.21</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">22472876</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC3837431</pub-id>.</mixed-citation></ref>
<ref id="c86"><label>86.</label><mixed-citation publication-type="journal"><article-title>Schizophrenia Working Group of the Psychiatric Genomics C. Biological insights from 108 schizophrenia-associated genetic loci</article-title>. <source>Nature</source>. <year>2014</year>;<volume>511</volume>(<issue>7510</issue>):<fpage>421</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature13595</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">25056061</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC4112379</pub-id>.</mixed-citation></ref>
<ref id="c87"><label>87.</label><mixed-citation publication-type="journal"><string-name><surname>Stahl</surname> <given-names>E</given-names></string-name>, <string-name><surname>Forstner</surname> <given-names>A</given-names></string-name>, <string-name><surname>McQuillin</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ripke</surname> <given-names>S</given-names></string-name>, <string-name><surname>Ophoff</surname> <given-names>R</given-names></string-name>, <string-name><surname>Scott</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal> <article-title>Genome-wide association study identifies 30 loci associated with bipolar disorder</article-title>. <source>bioRxiv</source>. <year>2017</year>. doi: <pub-id pub-id-type="doi">10.1101/173062</pub-id>.</mixed-citation></ref>
<ref id="c88"><label>88.</label><mixed-citation publication-type="journal"><string-name><surname>Purcell</surname> <given-names>S</given-names></string-name>, <string-name><surname>Neale</surname> <given-names>B</given-names></string-name>, <string-name><surname>Todd-Brown</surname> <given-names>K</given-names></string-name>, <string-name><surname>Thomas</surname> <given-names>L</given-names></string-name>, <string-name><surname>Ferreira</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Bender</surname> <given-names>D</given-names></string-name>, <etal>et al.</etal> <article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses</article-title>. <source>American journal of human genetics</source>. <year>2007</year>;<volume>81</volume>(<issue>3</issue>):<fpage>559</fpage>&#x2013;<lpage>75</lpage>. doi: <pub-id pub-id-type="doi">10.1086/519795</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">17701901</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC1950838</pub-id>.</mixed-citation></ref>
<ref id="c89"><label>89.</label><mixed-citation publication-type="journal"><string-name><surname>Dopazo</surname> <given-names>J</given-names></string-name>, <string-name><surname>Amadoz</surname> <given-names>A</given-names></string-name>, <string-name><surname>Bleda</surname> <given-names>M</given-names></string-name>, <string-name><surname>Garcia-Alonso</surname> <given-names>L</given-names></string-name>, <string-name><surname>Aleman</surname> <given-names>A</given-names></string-name>, <string-name><surname>Garcia-Garcia</surname> <given-names>F</given-names></string-name>, <etal>et al.</etal> <article-title>267 Spanish Exomes Reveal Population-Specific Differences in Disease-Related Genetic Variation</article-title>. <source>Molecular biology and evolution</source>. <year>2016</year>;<volume>33</volume>(<issue>5</issue>):<fpage>1205</fpage>&#x2013;<lpage>18</lpage>. doi: <pub-id pub-id-type="doi">10.1093/molbev/msw005</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">26764160</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC4839216</pub-id>.</mixed-citation></ref>
<ref id="c90"><label>90.</label><mixed-citation publication-type="journal"><string-name><surname>Puente</surname> <given-names>XS</given-names></string-name>, <string-name><surname>Bea</surname> <given-names>S</given-names></string-name>, <string-name><surname>Valdes-Mas</surname> <given-names>R</given-names></string-name>, <string-name><surname>Villamor</surname> <given-names>N</given-names></string-name>, <string-name><surname>Gutierrez-Abril</surname> <given-names>J</given-names></string-name>, <string-name><surname>Martin-Subero</surname> <given-names>JI</given-names></string-name>, <etal>et al.</etal> <article-title>Non-coding recurrent mutations in chronic lymphocytic leukaemia</article-title>. <source>Nature</source>. <year>2015</year>;<volume>526</volume>(<issue>7574</issue>):<fpage>519</fpage>&#x2013;<lpage>24</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature14666</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">26200345</pub-id>.</mixed-citation></ref>
<ref id="c91"><label>91.</label><mixed-citation publication-type="journal"><string-name><surname>Toma</surname> <given-names>C</given-names></string-name>, <string-name><surname>Torrico</surname> <given-names>B</given-names></string-name>, <string-name><surname>Hervas</surname> <given-names>A</given-names></string-name>, <string-name><surname>Valdes-Mas</surname> <given-names>R</given-names></string-name>, <string-name><surname>Tristan-Noguero</surname> <given-names>A</given-names></string-name>, <string-name><surname>Padillo</surname> <given-names>V</given-names></string-name>, <etal>et al.</etal> <article-title>Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations</article-title>. <source>Molecular psychiatry</source>. <year>2014</year>;<volume>19</volume>(<issue>7</issue>):<fpage>784</fpage>&#x2013;<lpage>90</lpage>. doi: <pub-id pub-id-type="doi">10.1038/mp.2013.106</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">23999528</pub-id>.</mixed-citation></ref>
<ref id="c92"><label>92.</label><mixed-citation publication-type="journal"><string-name><surname>Li</surname> <given-names>J</given-names></string-name>, <string-name><surname>Cai</surname> <given-names>T</given-names></string-name>, <string-name><surname>Jiang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>H</given-names></string-name>, <string-name><surname>He</surname> <given-names>X</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>C</given-names></string-name>, <etal>et al.</etal> <article-title>Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database</article-title>. <source>Molecular psychiatry</source>. <year>2016</year>;<volume>21</volume>(<issue>2</issue>):<fpage>290</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1038/mp.2015.40</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">25849321</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC4837654</pub-id>.</mixed-citation></ref>
<ref id="c93"><label>93.</label><mixed-citation publication-type="journal"><string-name><surname>Turner</surname> <given-names>TN</given-names></string-name>, <string-name><surname>Yi</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Krumm</surname> <given-names>N</given-names></string-name>, <string-name><surname>Huddleston</surname> <given-names>J</given-names></string-name>, <string-name><surname>Hoekzema</surname> <given-names>K</given-names></string-name>, <collab>HA FS</collab>, <etal>et al.</etal> <article-title>denovo-db: a compendium of human de novo variants</article-title>. <source>Nucleic acids research</source>. <year>2017</year>;<volume>45</volume>(<issue>D1</issue>):<fpage>D804</fpage>&#x2013;<lpage>D11</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkw865</pub-id>. PubMed PMID: <pub-id pub-id-type="pmid">27907889</pub-id>; PubMed Central PMCID: <pub-id pub-id-type="pmcid">PMC5210614</pub-id>.</mixed-citation></ref>
</ref-list>
<sec sec-type="supplementary-material">
<title>SUPPORTING INFORMATION</title>
<p><bold>S1 Table. Primers used in the CNV validation for the <italic>CNTNAP2</italic> intronic deletion.</bold></p>
<p><bold>S2 Table. Full list of <italic>de novo</italic> variants in <italic>CNTNAP2</italic> gene.</bold></p>
<p><bold>S3 Table. Full list of Ultra-Rare Variants (URVs) in available sequencing datasets</bold>.</p>
</sec>
</back>
</article>